NCT Number,Study Title,Study URL,Study Results,Conditions,Interventions,Sex,Age,Phases,Locations
NCT02269137,Assessment of Severity and Prognosis for Patients With Status Epileptics(SE),https://clinicaltrials.gov/study/NCT02269137,NO,Status Epileptics,,ALL,"CHILD, ADULT, OLDER_ADULT",,"The Department of Neurology, Xijing Hospital, Xi'an, Shaanxi, 710032, China"
NCT02560597,Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Epilepsy,https://clinicaltrials.gov/study/NCT02560597,NO,Epilepsia Partialis Continua|Status Epilepticus,PROCEDURE: repetitive transcranial magnetic stimulation,ALL,"ADULT, OLDER_ADULT",NA,"University Hospital, Ghent, Ghent, 9000, Belgium"
NCT03154307,Repeated TMS at Low Frequencies to Reduce Seizure Occurrence,https://clinicaltrials.gov/study/NCT03154307,YES,"Epilepsy|Status Epilepticus|Epilepsia Partialis Continua|Epilepsia Partialis Continua, Refractory (Medically)",DEVICE: Low frequency repeated TMS (LF-rTMS),ALL,"ADULT, OLDER_ADULT",NA,"Baptist Hospital of Miami, Miami, Florida, 33176, United States"
NCT02968966,Pathophysiology Based Therapy of Early Onset Epileptic Encephalopathies,https://clinicaltrials.gov/study/NCT02968966,NO,"Seizure, Epileptic",OTHER: Therapy regime,ALL,CHILD,PHASE2,"Universtiy Hospital, Tübingen, 72076, Germany"
NCT05459597,Antiepileptic Drugs in Elderly Patients,https://clinicaltrials.gov/study/NCT05459597,NO,"Seizure, Epileptic",DRUG: antiepileptic drugs,ALL,OLDER_ADULT,,"Wei Zhao, Jinan, Shandong, China"
NCT01116700,Dexmedetomidine in Seizure Patients,https://clinicaltrials.gov/study/NCT01116700,NO,Seizure Disorders,DRUG: Dexmedetomidine,ALL,"ADULT, OLDER_ADULT",PHASE1,"University of California San Francisco, San Francisco, California, 94122, United States"
NCT05431595,Managing Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing Strategy,https://clinicaltrials.gov/study/NCT05431595,NO,Delirium|Epileptics|Neuroleptics,DRUG: Haloperidol|DRUG: Chlorpromazine|DRUG: Valproate|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,"MD Anderson Cancer Center, Houston, Texas, 77030, United States"
NCT03860467,Epileptic Seizures in Intensive Care Units,https://clinicaltrials.gov/study/NCT03860467,NO,Epileptic Seizure,OTHER: collection of patient data,ALL,"ADULT, OLDER_ADULT",,"Clinic for Intensive Care Medicine, University Hospital Basel, Basel, 4031, Switzerland"
NCT02229318,A Taste and Acceptance Study of FruitiVits in Children Aged 4-8 Years Following a Ketogenic Diet.,https://clinicaltrials.gov/study/NCT02229318,YES,Seizure Disorders,DIETARY_SUPPLEMENT: FruitiVits,ALL,CHILD,NA,"The Children's Hospital of Philadelphia, Division of Neurology, Philadelphia, Pennsylvania, 19104, United States"
NCT01159431,External Trigeminal Nerve Stimulation for Epilepsy,https://clinicaltrials.gov/study/NCT01159431,YES,Epilepsy|Seizure Disorders,DEVICE: Trigeminal Nerve Stimulation,ALL,"ADULT, OLDER_ADULT",PHASE2,"USC Department of Neurology, Los Angeles, California, 90033, United States|Olive View/UCLA Medical Center, Sylmar, California, 91342, United States"
NCT02304029,Usefulness of Sodium MRI in the Presurgical Assessment of Drug-resistant Partial Epilepsy,https://clinicaltrials.gov/study/NCT02304029,NO,Epileptic Seizures,DEVICE: MRI,ALL,"ADULT, OLDER_ADULT",NA,"Assistance Publique - Hopitaux de Marseille, Marseille, 13005, France|CHU Montpellier, Montpellier, France|CHU NICE, Nice, France|CHU Nimes, Nimes, France"
NCT05567042,A Clinical Study of Epilepsy Localization and Prognosis Based on PET and Resting-state fMRI,https://clinicaltrials.gov/study/NCT05567042,NO,Epileptic Seizure,OTHER: No intervention,ALL,"CHILD, ADULT, OLDER_ADULT",,
NCT01351727,Epidemiologic Follow Up Study of Newly Diagnosed Epilepsy Among Seniors,https://clinicaltrials.gov/study/NCT01351727,NO,Epileptic Seizures,,ALL,OLDER_ADULT,,"Pima, Cochise, Santa Cruz Counties, Tucson, Arizona, 85724, United States"
NCT02134366,Clobazam Use in Epilepsia Partialis Continua - Pilot Study,https://clinicaltrials.gov/study/NCT02134366,NO,Epilepsia Partialis Continua|Kojewnikov's Epilepsy|Epilepsy,DRUG: Clobazam|DRUG: Clonazepam|DRUG: Lorazepam,ALL,"ADULT, OLDER_ADULT",PHASE3,"Cooper Universtiy Hospital, Camden, New Jersey, 08103, United States"
NCT04204863,Status Epilepticus Population Study (STEPS),https://clinicaltrials.gov/study/NCT04204863,NO,Epileptic Seizures,OTHER: collection of patient data,ALL,"ADULT, OLDER_ADULT",,"Cantonal Hospital Aarau (KSA), Aarau, 5001, Switzerland|Clinic for Intensive Care Medicine, University Hospital Basel, Basel, 4031, Switzerland"
NCT05725174,Volatile Non-Invasive Biomarkers of Epileptic Seizures,https://clinicaltrials.gov/study/NCT05725174,NO,Epilepsy|Non-Epileptic Seizure,OTHER: Sample Collection,ALL,"ADULT, OLDER_ADULT",,"Chalfont Centre for Epilepsy, London, Buckinghamshire, SL9 0RJ, United Kingdom|National Hospital for Neurology and Neurosurgery, London, WC1N 3BG, United Kingdom"
NCT05241366,TMS vs Conventional Therapy for the Treatment of Functional Neurological Non Epileptic Seizure Disorder,https://clinicaltrials.gov/study/NCT05241366,NO,Psychogenic Non-Epileptic Seizure,DEVICE: Transcranial Magnetic Stimulation|DEVICE: Sham Transcranial Magnetic Stimulation coil,ALL,"ADULT, OLDER_ADULT",NA,"Instituto Nacional de Neurologia Y Neurocirugia Mvs, Mexico, Ciudad De Mexico, 14269, Mexico"
NCT01313260,Structural and Functional Connectivity in Partial Epilepsies Studied With MRI and MEG,https://clinicaltrials.gov/study/NCT01313260,NO,Epilepsies,,ALL,ADULT,,"ICM (Brain and Spine Institute), Paris, 75013, France"
NCT04572243,A Study of Lorcaserin as Adjunctive Treatment in Participants With Dravet Syndrome,https://clinicaltrials.gov/study/NCT04572243,NO,"Epilepsies, Myoclonic",DRUG: Placebo|DRUG: Lorcaserin,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"Children's of Alabama / University of Alabama at Birmingham, Birmingham, Alabama, 35226, United States|University of California Los Angeles (UCLA), Los Angeles, California, 90095, United States|UCSD Rady's Children's Hosptial, San Diego, California, 92123, United States|Children's Hospital Colorado, Aurora, Colorado, 80045, United States|Northwest Florida Clinical Research Group, Gulf Breeze, Florida, 32561, United States|Joe DiMaggio Children's Hospital, Hollywood, Florida, 33021, United States|Miami Children's Hospital - Nicklaus Children's Hospital, Miami, Florida, 33155, United States|Pediatric Neurology, P.A., Winter Park, Florida, 32789, United States|Rare Disease Research Center Pediatrics, LLC, Atlanta, Georgia, 30318, United States|Mid-Atlantic Epilepsy and Sleep Center - Bethesda, Bethesda, Maryland, 20817, United States|Spectrum Health/ Helen DeVos Children's Hospital, Grand Rapids, Michigan, 49503, United States|University of Missouri, Department of Child Health, Division of Neurology, Columbia, Missouri, 65201, United States|Institute of Neurology and Neurosurgery at Saint Barnabas, Livingston, New Jersey, 07039, United States|Northwell Health - Neuroscience Institute at Great Neck, New Hyde Park, New York, 10075, United States|NYU Langone Comprehensive Epilepsy Center, New York, New York, 10016, United States|New York Medical College, New York, New York, 10019-1147, United States|NorthWell Health - Lennox Hill Hospital, New York, New York, 11021, United States|University of Rochester Medical Center, Rochester, New York, 14642, United States|University of North Carolina, Chapel Hill, North Carolina, 27599-7025, United States|Duke University Hospital Center, Durham, North Carolina, 27710, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, 44106, United States|Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, 15224, United States|The University of Texas Health Science Center at Houston, Houston, Texas, 77030, United States|Seattle Children's Hospital, Seattle, Washington, 98105, United States|MultiCare Institute for Research & Innovation, Tacoma, Washington, 98405, United States|Alberta Children's Hospital, Calgary, Alberta, AB T3B 6A8, Canada|Stollery Children's Hospital, Edmonton, Alberta, T6G 1C9, Canada|BC Children's Hospital, Vancouver, British Columbia, V6H 3N1, Canada|Children's Hospital - VH, London Health Sciences Centre, London, Ontario, N6A 4G5, Canada|University of Toronto Division of Hematology Oncology/The Hospital for Sick Children, Toronto, Ontario, M5G 1X8, Canada"
NCT06143241,Cognitive Function and Glymphatic System in Children With Epilepsy,https://clinicaltrials.gov/study/NCT06143241,NO,"Epilepsy|Cognitive Dysfunction|Seizure, Epileptic",DEVICE: Threshold IMT|DRUG: Antiepileptic medication,ALL,CHILD,NA,"Ege University, Izmir, Bornova, 35080, Turkey"
NCT01450423,Physical Exercise in Subjects With Juvenile Myoclonic Epilepsy,https://clinicaltrials.gov/study/NCT01450423,NO,Epilepsy|Epilepsia|Epileptic Seizures|Seizure Disorder,BEHAVIORAL: Physical activity,ALL,"CHILD, ADULT",PHASE2,"Center of Research in Childhood Health, University of Southern Denmark, Odense, Region of Southern Denmark, 5000, Denmark|Epilepsy clinic, Odense University Hospital, Odense, Region of Southern Denmark, 5000, Denmark"
NCT03329703,Project UPLIFT for Psychogenic Non-Epileptic Seizures,https://clinicaltrials.gov/study/NCT03329703,NO,Psychogenic Non-Epileptic Seizure|Depression|Non-Epileptic Seizure|Psychogenic Seizure,BEHAVIORAL: Project UPLIFT,ALL,"ADULT, OLDER_ADULT",NA,"Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, 03756, United States"
NCT04061707,Subcutaneous EEG: Forecasting of Epileptic Seizures,https://clinicaltrials.gov/study/NCT04061707,NO,"Epilepsies, Focal",,ALL,"ADULT, OLDER_ADULT",,"King's College Hospital NHS Foundation Trust, London, SE5 9RS, United Kingdom"
NCT01978470,External Trigeminal Nerve Stimulation for Drug Resistent Epilepsy,https://clinicaltrials.gov/study/NCT01978470,NO,Seizure Disorder,DEVICE: External Trigeminal Nerve Stimulation (eTNS),ALL,"ADULT, OLDER_ADULT",NA,"Olive View/UCLA Medical Center, Sylmar, California, United States"
NCT00542802,Levetiracetam Versus Carbamazepine in Post-Stroke Late Onset Crisis,https://clinicaltrials.gov/study/NCT00542802,NO,Epileptic Seizures|Stroke,DRUG: Levetiracetam|DRUG: Carbamazepine,ALL,"ADULT, OLDER_ADULT",PHASE3,"Ospedale S. Giacomo, Novi Ligure, AL, 15057, Italy|Ospedale S. Croce E Carle, Cuneo, CN, 12100, Italy|Ospedale S. Martino, Genova, GE, 16132, Italy|Istituto Clinico Humanitas, Rozzano, MI, 20089, Italy|USL 2 Ospedale B.G. Villa, Città della Pieve, PG, 06062, Italy|Ospedale Civile San Giovanni Battista di Foligno, Foligno, PG, Italy|Ospedale Santa Maria della Misericordia, Sant'Andrea delle Fratte, PG, 06131, Italy|Istituto Neurologico C. Mondino, Pavia, PV, 27100, Italy|Ospedale Guzzardi, Vittoria, RG, 97019, Italy|Ospedale Di Portogruaro, Portogruaro, VE, 30026, Italy|Ospedale Civile, Vibo Valentia, VV, 89900, Italy|Policlinico Umberto I, Ancona, 60020, Italy|Ospedale A. Perrino, Brindisi, 72100, Italy|Ospedale Cannizzaro, Catania, 95126, Italy|Ospedale San Martino, Genova, Italy|Ospedale Civile Imperia ASL 1, Imperia, 18100, Italy|Ospedale A. Cardarelli-, Napoli, 80131, Italy|Ospedale Cardarelli, Napoli, 80131, Italy|Ospedale Civico, Palermo, 90100, Italy|Osp. Guglielmo da saliceto, Piacenza, 29100, Italy|Arcispedale S. Maria Nuova, Reggio Emilia, 42100, Italy|Ospedale SS. Annunziata - Ospedale Civile, Taranto, Italy|Ospedale Molinette-Università di Torino, Torino, Italy|Azienda Ospedaliera Universitaria Trieste, Trieste, 34149, Italy"
NCT02976545,Emotional Lived in Patients Suffering From Psychogenic Nonepileptic Seizures : Study by Functional Magnetic Resonance Imaging,https://clinicaltrials.gov/study/NCT02976545,NO,Psychogenic Non-epileptic Seizures,DEVICE: fMRI (functional Magnetic Resonance Imaging)|BEHAVIORAL: psychiatric evaluation,FEMALE,"ADULT, OLDER_ADULT",NA,"CHRU de Nancy, Nancy, 54000, France"
NCT06374966,Real-world Study of Efficacy and Safety of Zonisamide in add-on Therapy for Patients With Focal Epilepsy,https://clinicaltrials.gov/study/NCT06374966,NO,"Epilepsies, Partial",DRUG: Zonisamide,ALL,"CHILD, ADULT, OLDER_ADULT",,"Hangzhou Children's Hospital, Hangzhou, Zhejiang, 310005, China|The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310009, China|Huzhou Third People's Hospital, Huzhou, Zhejiang, 313002, China|Jiaxing Second hospital, Jiaxing, Zhejiang, 314099, China|Jinhua Second hospital, Jinhua, Zhejiang, 321016, China|The Fourth Affilicated Hospital of Zhejiang University School of Medicine, Jinhua, Zhejiang, 322099, China|Lishui People's Hospital, Lishui, Zhejiang, 323050, China|Ningbo Women And Children's Hospital, Ningbo, Zhejiang, 315012, China|Ningbo Medical center Lihuili hospital, Ningbo, Zhejiang, 315048, China|Yuyao People's hospital, Yuyao, Zhejiang, 315499, China"
NCT05958069,The Efficacy and Safety of Minocycline in the Treatment of Drug-resistant Epilepsy in NORSE Patients,https://clinicaltrials.gov/study/NCT05958069,NO,Epileptic Seizures Related to Drugs,DRUG: minocycline,ALL,"CHILD, ADULT, OLDER_ADULT",NA,"XijingHospital, Xi'an, Shaanxi, 710032, China"
NCT05419180,Study of Interest of Stiripentol and Carbamazepine in the Treatment of Patients With Pharmacoresistant Focal Epilepsies,https://clinicaltrials.gov/study/NCT05419180,NO,Pharmacoresistant Focal Epilepsies,DRUG: Stiripentol,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,"Centre de Référence Epilepsies Rares / Centre Investigation Clinique (CIC) - Hôpital Necker-Enfants Malades, Paris, 75015, France"
NCT03533374,Validation of Criteria for Identification of Epileptiform Discharges in EEG Recordings of Patients With Epilepsy,https://clinicaltrials.gov/study/NCT03533374,YES,Epilepsy|Non-Epileptic Seizure,DIAGNOSTIC_TEST: Electroencephalogram (EEG) and visual evaluation,ALL,"CHILD, ADULT, OLDER_ADULT",,
NCT04309812,Transcranial Direct Current to Treat Epilepsy at Home,https://clinicaltrials.gov/study/NCT04309812,NO,"Epilepsies, Partial",DEVICE: transcranial direct current stimulation (tDCS),ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,"Stanford Hospital, Stanford, California, 94305-5235, United States|Stanford University School of Medicine, Stanford, California, 94305-5235, United States"
NCT06222840,Electro-clinical Features and Functional Connectivity Analysis in SYN1 Gene Mutation-related Epilepsy,https://clinicaltrials.gov/study/NCT06222840,NO,Epileptic Syndromes,OTHER: Electro-clinical analysis of epileptic seizures|OTHER: Electro-encephalographic cases|OTHER: Clinical datas analysis|OTHER: Electro-encephalographic control,ALL,"CHILD, ADULT, OLDER_ADULT",,"CHU Saint Etienne, Saint-Étienne, 42000, France"
NCT01663545,Brain P-gp and Inflammation in People With Epilepsy,https://clinicaltrials.gov/study/NCT01663545,NO,"Epilepsies, Partial",,ALL,ADULT,,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States"
NCT03054961,Cerebral Oxygen Saturation and Cytochrome Oxidase REDOX State in Children With Epilepsy: A Pilot Study,https://clinicaltrials.gov/study/NCT03054961,NO,"Epilepsies, Partial",DEVICE: Near-infrared spectroscopy,ALL,"CHILD, ADULT, OLDER_ADULT",,"The Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States"
NCT06223334,Epileptic Syndromes in Infants and Early Childhood,https://clinicaltrials.gov/study/NCT06223334,NO,Epileptic Syndromes,OTHER: No intervention,ALL,CHILD,,"Assiut child university hospital, Assiut, 71515, Egypt|AlAzhar university hospital Assiut branch, Assiut, 71524, Egypt"
NCT03882151,Added Value of Automated Electrical Source Localization (EPILOG PreOp®) to Presurgical Evaluation of Refractory Epilepsy,https://clinicaltrials.gov/study/NCT03882151,NO,"Epilepsies, Partial",DIAGNOSTIC_TEST: electrical source imaging,ALL,"CHILD, ADULT, OLDER_ADULT",NA,"Saint-Luc University Hospital, Brussels, 1200, Belgium|Centre Hospitalier William Lennox, Ottignies, 1340, Belgium"
NCT03689114,"Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW)",https://clinicaltrials.gov/study/NCT03689114,NO,"Epilepsies, Partial",DRUG: Low dose carbamazepine|DRUG: Standard dose carbamazepine|DRUG: Low dose levetiracetam|DRUG: Standard dose levetiracetam|DRUG: Low dose valproate|DRUG: Standard dose valproate|DRUG: Low dose zonisamide|DRUG: Standard dose zonisamide|DRUG: Low dose oxcarbazepine|DRUG: Standard dose oxcarbazepine|DRUG: Low dose topiramate|DRUG: Standard dose topiramate|DRUG: Low dose lamotrigine|DRUG: Standard dose lamotrigine|DRUG: Low dose gabapentin|DRUG: Standard dose gabapentin,ALL,"ADULT, OLDER_ADULT",PHASE4,"ASST Monza Ospedale San Gerardo, Monza, 20900, Italy"
NCT03484039,Incorporating Multidimensional Psychosocial Interventions Improves the Well-being of Individuals With Epilepsy,https://clinicaltrials.gov/study/NCT03484039,NO,Epilepsy|Seizure Disorder,BEHAVIORAL: Medication Adherence|BEHAVIORAL: Seizure Documentation|BEHAVIORAL: Memory Improvement|BEHAVIORAL: Stress Management,ALL,"ADULT, OLDER_ADULT",NA,"UF Health Jacksonville, Jacksonville, Florida, 32209, United States"
NCT01919307,Auricular Acupuncture For The Treatment Of Non-Epileptic Seizures,https://clinicaltrials.gov/study/NCT01919307,YES,"Convulsion, Non-Epileptic",OTHER: Auricular acupuncture,ALL,"ADULT, OLDER_ADULT",NA,"Denver Health Medical Center, Denver, Colorado, 80204, United States"
NCT05273398,Effects of Diazepam on RNS Detections,https://clinicaltrials.gov/study/NCT05273398,NO,"Epilepsies, Partial",DRUG: nasal diazepam,ALL,"ADULT, OLDER_ADULT",PHASE4,"University of Cincinnati, Cincinnati, Ohio, 45267, United States"
NCT01762215,Policy on Optimal Epilepsy Management,https://clinicaltrials.gov/study/NCT01762215,NO,Epilepsy|Seizure Disorder,BEHAVIORAL: PatientsLikeMe.com,ALL,"ADULT, OLDER_ADULT",NA,"San Francisco VA Medical Center, San Francisco, California, 94121, United States"
NCT01745952,Treatment of Difficult to Control Focal Epilepsy With Repetitive Transcranial Magnetic Stimulation (rTMS),https://clinicaltrials.gov/study/NCT01745952,YES,"Epilepsies, Partial",DEVICE: figure-of-eight active rTMS coil|DEVICE: round active rTMS coil|DEVICE: sham rTMS coil (figure-of-eight),ALL,"CHILD, ADULT, OLDER_ADULT",NA,"University Hospitals Leuven, department of Neurology, Leuven, 3000, Belgium"
NCT02311829,Evaluation of a Telephone Follow-up Procedure on the Quality of Life in Psychogenic Non-epileptic Seizures,https://clinicaltrials.gov/study/NCT02311829,NO,Psychogenic Non Epileptic Seizure,OTHER: Telephone follow-up device,ALL,"ADULT, OLDER_ADULT",NA,"Chu Strasbourg, Strasbourg, Alsace, 67 098, France|Chu Dijon, Dijon, Bourgogne, 21 079, France|Chu Reims, Reims, Champagne Ardennes, 51 092, France|Chu Nancy, Nancy, Lorraine, 54 035, France"
NCT02635633,"Continuous Thetaburst Stimulation for the Treatment of Refractory Epilepsy - Safety, Feasibility and Proof-of-concept",https://clinicaltrials.gov/study/NCT02635633,NO,"Epilepsies, Partial",DEVICE: continuous thetaburst stimulation,ALL,"ADULT, OLDER_ADULT",NA,"University Hospital Ghent, Ghent, 9000, Belgium"
NCT00179426,Effect of Antiseizure Medication on Hormone Levels and Sexual Function in Men With Epilepsy,https://clinicaltrials.gov/study/NCT00179426,NO,Seizure Disorder|Epilepsy,,MALE,ADULT,,"Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States"
NCT00955357,Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures,https://clinicaltrials.gov/study/NCT00955357,YES,Partial Epilepsies,DRUG: Lacosamide,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,"103, Irvine, California, United States|123, Rancho Mirage, California, United States|156, Clearwater, Florida, United States|157, Destin, Florida, United States|140, Hollywood, Florida, United States|161, Ocala, Florida, United States|108, Atlanta, Georgia, United States|112, Atlanta, Georgia, United States|124, Augusta, Georgia, United States|115, Macon, Georgia, United States|118, Rome, Georgia, United States|128, Flossmoor, Illinois, United States|130, Des Moines, Iowa, United States|102, Bowling Green, Kentucky, United States|117, Paducah, Kentucky, United States|107, Houma, Louisiana, United States|145, Ruston, Louisiana, United States|101, Annapolis, Maryland, United States|162, Waldorf, Maryland, United States|153, Boston, Massachusetts, United States|136, Pittsfield, Massachusetts, United States|144, Springfield, Massachusetts, United States|151, Kansas City, Missouri, United States|114, Paterson, New Jersey, United States|109, Brooklyn, New York, United States|133, Brooklyn, New York, United States|127, West Seneca, New York, United States|158, Charlotte, North Carolina, United States|139, Bismarck, North Dakota, United States|134, Akron, Ohio, United States|150, Canton, Ohio, United States|141, Tulsa, Oklahoma, United States|121, Indiana, Pennsylvania, United States|120, Columbia, South Carolina, United States|149, Orangeburg, South Carolina, United States|152, Spartanburg, South Carolina, United States|148, Austin, Texas, United States|154, Dallas, Texas, United States|146, Tomball, Texas, United States|119, Fredericksburg, Virginia, United States|503, Wien, Austria|703, Blagoevrad, Bulgaria|706, Pleven, Bulgaria|700, Sofia, Bulgaria|702, Sofia, Bulgaria|704, Sofia, Bulgaria|705, Sofia, Bulgaria|707, Sofia, Bulgaria|708, Sofia, Bulgaria|701, Varna, Bulgaria|736, Hradec Kralove, Czechia|735, Litomerice, Czechia|732, Ostrava-Hrabuvka, Czechia|733, Ostrava, Czechia|737, Praha 11, Czechia|734, Trutnov, Czechia|930, Aarhus, Denmark|400, Helsinki, Finland|402, Oulu, Finland|401, Tampere, Finland|610, Strasbourg, France|611, Toulon, France|521, Athens, Greece|520, Thessaloniki, Greece|552, Faenza, Italy|546, Gallarate, Italy|541, Napoli, Italy|559, Pietra Ligure, Italy|557, Prato, Italy|540, Roma, Italy|549, Roma, Italy|542, Taranto, Italy|547, Torino, Italy|551, Trieste, Italy|180, Aguascalientes, Mexico|183, Chihuahua, Mexico|185, Chihuahua, Mexico|184, Ciudad Juarez, Mexico|189, Guadalajara, Mexico|181, Mexico DF, Mexico|193, Mexico DF, Mexico|195, Mexico DF, Mexico|186, Monterrey, Mexico|187, Monterrey, Mexico|188, Monterrey, Mexico|182, Polanco, Mexico|815, Bucarest, Romania|810, Cluj-napoca, Romania|814, Oradea, Romania|813, Targu Mures, Romania|830, Kazan, Russian Federation|831, Kazan, Russian Federation|834, Moscow, Russian Federation|833, Novosibirsk, Russian Federation|598, Terrassa, Barcelona, Spain|592, Almeria, Spain|597, Bajo Sevilla, Spain|590, Barcelona, Spain|596, Santiago de Compostela, Spain|594, Valencia, Spain|599, Valladolid, Spain|892, Lausanne, Switzerland|713, Adana, Turkey|714, Ankara, Turkey|710, Eskisehir, Turkey|711, Istanbul, Turkey|719, Istanbul, Turkey|717, Izmir, Turkey|718, Trabzon, Turkey"
NCT00280696,A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset Seizures,https://clinicaltrials.gov/study/NCT00280696,NO,"Epilepsies, Partial",DRUG: Levetiracetam 250 mg|DRUG: Levetiracetam 500 mg|OTHER: Placebo,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"Aichi-gun, Aichi, Japan|Nagoya, Aichi, Japan|Nayoga, Aichi, Japan|Hirosaki, Aomori, Japan|Kitakyusyu, Fukuoka, Japan|Kurume, Fukuoka, Japan|Fukuyama, Hiroshima, Japan|Asahikawa, Hokkaido, Japan|Hakodate, Hokkaido, Japan|Sapporo, Hokkaido, Japan|Kobe, Hyogo, Japan|Kahoku-gun, Ishikawa, Japan|Kikuchi-gun, Kumamoto, Japan|Sendai, Miyagi, Japan|Omura, Nagasaki, Japan|Izumi, Osaka, Japan|Neyagawa, Osaka, Japan|Suita, Osaka, Japan|Kawachi-gun, Tochigi, Japan|Kodaira, Tokyo, Japan|Ube, Yamaguchi, Japan|Chiba, Japan|Fukuoka, Japan|Gihu, Japan|Hiroshima, Japan|Kagoshima, Japan|Kobe, Japan|Kyoto, Japan|Miyazaki, Japan|Nagaoka, Japan|Niigata, Japan|Okayama, Japan|Osaka, Japan|Shizuoka, Japan|Tokyo, Japan|Toyama, Japan|Yamagata, Japan"
NCT03807141,Evaluation of the Modified Atkins Diet in Children With Epileptic Spasms,https://clinicaltrials.gov/study/NCT03807141,NO,Epileptic Spasms,OTHER: Modified Atkins diet,ALL,CHILD,PHASE2|PHASE3,"Lady Hardinge Medical College, New Delhi, Delhi, 110018, India"
NCT04802135,Creation of a Register of Patients With Neonatal-onset Epileptic Encephalopathy,https://clinicaltrials.gov/study/NCT04802135,NO,Epileptic Encephalopathy,OTHER: Survey,ALL,"CHILD, ADULT, OLDER_ADULT",,"CHU Angers, Angers, France|CHU Bordeaux, Bordeaux, France|CHU Brest, Brest, France|CHRU Lille, Lille, France|CHU Limoges, Limoges, France|Hospices Civils Lyon, Lyon, France|Hôpital La Timone, Marseille, 13005, France|CHU Montpellier, Montpellier, France|APHP Pitié Salpêtrière, Paris, France|APHP Robert Debré, Paris, France|Hôpital Necker, Paris, France|CHU Rennes, Rennes, France|CHRU Strasbourg, Strasbourg, France|CHU Toulouse, Toulouse, France|CHU Tours, Tours, France"
NCT00255411,Psychiatric Correlates of Psychogenic Movement Disorder and Non-Epileptic Seizure,https://clinicaltrials.gov/study/NCT00255411,NO,Psychogenic Movement Disorders|Non-epileptic Seizures,,ALL,"ADULT, OLDER_ADULT",,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States"
NCT04147663,Epidemiology of Suspected Epileptic Seizures,https://clinicaltrials.gov/study/NCT04147663,NO,Epilepsy,OTHER: describe the management of the adult population suffering from suspected seizure by the emergency structures,ALL,"ADULT, OLDER_ADULT",,"Centre Hospitalier St Joseph St Luc, Lyon, 69007, France"
NCT00212745,Pilot Trial of a Behavioral Treatment for Epilepsy,https://clinicaltrials.gov/study/NCT00212745,NO,"Epilepsies, Partial",BEHAVIORAL: Andrews/Reiter behavioral treatment for epilepsy,ALL,"CHILD, ADULT",PHASE1|PHASE2,"Oregon Health and Science University, Portland, Oregon, 97239, United States"
NCT01235403,Trial to Assess Optimized Dosage of Lacosamide as add-on Therapy in Patients With Partial Onset Seizure,https://clinicaltrials.gov/study/NCT01235403,YES,Partial Epilepsies,DRUG: Lacosamide,ALL,"ADULT, OLDER_ADULT",PHASE4,"Amiens, France|Aubenas, France|Auxerre, France|Bordeaux, France|Brest, France|Caen, France|Carpentras, France|Chateaubriand, France|Colmar, France|Créteil, France|Gap, France|Gonesse, France|La Rochelle, France|Laval, France|Limoges, France|Marseille, France|Montluçon, France|Nice, France|Nîmes, France|Paris, France|Perpignan, France|Poitiers, France|Pringy, France|Rennes, France|Rouen, France|Saint Aubin Sur Cie, France|Saint Julien En Gengvois, France|Saint-Malo, France|St Brieuc, France|Toulouse, France|Vienne, France|Villeurbanne, France"
NCT00072813,MRI in Autosomal Dominant Partial Epilepsy With Auditory Features,https://clinicaltrials.gov/study/NCT00072813,NO,"Epilepsies, Partial",,ALL,"ADULT, OLDER_ADULT",,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States|Columbia University, New York, New York, 10032-3784, United States"
NCT00771927,Post-Authorization Safety Study to Assess the Safety of Vimpat as add-on Therapy in Patients With Partial-onset Seizures,https://clinicaltrials.gov/study/NCT00771927,YES,"Epilepsies, Partial",DRUG: Lacosamide,ALL,"CHILD, ADULT, OLDER_ADULT",,"Bron, France|Dijon, France|La Tronche, France|Montpellier, France|Nantes, France|Paris, France|Saint Brieuc, France|Tain L'Hermitage, France|Aschaffenburg, Germany|Bad Berka, Germany|Berlin, Germany|Bernau, Germany|Bielefeld, Germany|Bonn, Germany|Dresden, Germany|Dusseldorf, Germany|Erlangen, Germany|Essen, Germany|Freiburg, Germany|Gottingen, Germany|Halle, Germany|Hamburg, Germany|Jena, Germany|Kehl-Kork, Germany|Kiel, Germany|Koningstein-Falkenstein, Germany|Krefeld, Germany|Mainz, Germany|Marburg, Germany|Munster, Germany|München, Germany|Neuburg, Germany|Neukirchen-Vluyn, Germany|Oldenburg, Germany|Osnabruck, Germany|Potsdam, Germany|Radeberg, Sachsen, Germany|Ravensburg, Germany|Rotenburg/Wümme, Germany|Stuttgart, Germany|Ulm, Germany|Vogtareuth, Germany|Westerstede, Germany|Blaricum, Netherlands|Heeze, Netherlands|Nijmegen, Netherlands|Barcelona, Spain|El Vendrell, Spain|Plymouth, Devon, United Kingdom|Fulwood, Preston, Lancashire, United Kingdom|Bangor, United Kingdom|Birmingham, United Kingdom|Cardiff, United Kingdom|Dundee, United Kingdom|Edinburgh, United Kingdom|Leeds, United Kingdom|Leicester, United Kingdom|London, United Kingdom|Middlesborough, United Kingdom|Salford, United Kingdom|Sheffield, United Kingdom|Stoke on Trent, United Kingdom"
NCT00918047,Study of PK and Safety of OXC (Oxcarbazepine) XR (Extended Release) as Adjunctive Therapy in Pediatric Epilepsy Patients,https://clinicaltrials.gov/study/NCT00918047,NO,"Epilepsies, Partial",DRUG: SPN-804O,ALL,CHILD,PHASE1,"Little Rock, Arkansas, United States|Loxahatchee Groves, Florida, United States|Tampa, Florida, United States|Rockville, Maryland, United States|Lake Success, New York, United States|Rochester, New York, United States|Kingsport, Tennessee, United States|San Antonio, Texas, United States"
NCT03169751,An Exploratory Trial Using sEMG to Differentiate PNES From Epileptic Seizures,https://clinicaltrials.gov/study/NCT03169751,NO,Non-Epileptic Seizure|Motor Seizure|Epilepsy,DEVICE: Brain Sentinel Monitoring and Alerting System,ALL,"ADULT, OLDER_ADULT",,"Krankenhaus Hietzing mit Neurologischem Zentrum Rosenhugel, Wien, 1130, Austria"
NCT00512317,Open-label Extension to Protocol 1042-0600,https://clinicaltrials.gov/study/NCT00512317,YES,"Epilepsies, Partial",DRUG: ganaxolone,ALL,"ADULT, OLDER_ADULT",PHASE2,"University of Alabama, Birmingham, Alabama, 35294-0021, United States|Barrow Neurological Institute, Phoenix, Arizona, 85013, United States|Arkansas Epilepsy Program, Little Rock, Arkansas, 72205, United States|University of Southern California Adult Comprehensive Epilepsy Center, Los Angeles, California, 90033, United States|University of California-Davis, Sacramento, California, 95817, United States|Anchutz Outpatient Pavillion Neurosciences Clinic/ University of Colorado Hospital, Aurora, Colorado, 80010-0045, United States|Yale University School of Medicine, New Haven, Connecticut, 06520, United States|University of Florida McKnight Brain Institute, Gainesville, Florida, 32610-0236, United States|Intercoastal Neurology, Sarasota, Florida, 34232, United States|Emory HealthCare, Atlanta, Georgia, 30322, United States|Southern Illinois University Medical Center, Springfield, Illinois, 62702, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, 52242, United States|University of Kentucky, Dept. of Neurology, Lexington, Kentucky, 40536, United States|Mid-Atlantic Epilepsy and Sleep Center, Bethesda, Maryland, 20817, United States|2799 West Grand blvd. CFP 071, Detroit, Michigan, 48202, United States|Minnesota Epilepsy Group, PA, Saint Paul, Minnesota, 55102-2383, United States|Comprehensive Epilepsy Care Center for Children and Adults, Chesterfield, Missouri, 63017, United States|Neurosciences Institute at Albany Medical Center, Albany, New York, 12208, United States|SUNY Upstate Medical University, Syracuse, New York, 13210, United States|Ohio State University Medical Center, Columbus, Ohio, 43210, United States|Riddle Health Care Center for Neuroscience, Media, Pennsylvania, 19063, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, 19107, United States|Vanderbilt University Medical Center, Nashville, Tennessee, 37232, United States|Neurological Clinic of Texas, P.A., Dallas, Texas, 75230, United States|Virginia Commonwealth University, Richmond, Virginia, 23298, United States"
NCT02598076,Motivational Interviewing to Enhance Adherence of Patients With Psychogenic Non-epileptic Seizures,https://clinicaltrials.gov/study/NCT02598076,YES,"Psychogenic Non-epileptic Seizures, Motivational Interviewing",BEHAVIORAL: motivational interviewing|BEHAVIORAL: standard psychotherapy,ALL,"ADULT, OLDER_ADULT",NA,"Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States"
NCT01098162,Vimpat® Added as Adjunctive Therapy to One Baseline Antiepileptic Drug,https://clinicaltrials.gov/study/NCT01098162,YES,"Epilepsies, Partial",,ALL,"CHILD, ADULT, OLDER_ADULT",,"55, Aachen, Germany|119, Aalen, Germany|194, Aichach, Germany|191, Altenburg, Germany|136, Alzenau, Germany|78, Aschaffenburg, Germany|35, Bad Berka, Germany|90, Baesweiler, Germany|107, Berlin, Germany|10A, Berlin, Germany|141, Berlin, Germany|25, Berlin, Germany|49, Berlin, Germany|66, Berlin, Germany|75, Berlin, Germany|36, Bielefeld, Germany|5, Bonn, Germany|175, Brandenburg, Germany|192, Böblingen, Germany|105, Chemnitz, Germany|182, Coppenbrügge, Germany|161, Dortmund, Germany|128, Dresden, Germany|21, Dresden, Germany|39, Dresden, Germany|111, Düren, Germany|38, Düsseldorf, Germany|7, Eberswalde, Germany|102, Eisenach, Germany|174, Eisenach, Germany|56, Ellwangen, Germany|50, Erbach, Germany|179, Erfurt, Germany|186, Erfurt, Germany|6, Erlangen, Germany|12, Essen, Germany|27, Freiburg, Germany|137, Fulda, Germany|112, Gelsenkirchen, Germany|103, Gera, Germany|1, Greifswald, Germany|47, Grevenbroich, Germany|158, Göttingen, Germany|65, Göttingen, Germany|88, Göttingen, Germany|134, Halle (Saale), Germany|160, Hamburg, Germany|71, Hamburg, Germany|93, Hamm, Germany|147, Heilbronn, Germany|122, Herborn, Germany|15, Herdecke, Germany|130, Höchberg, Germany|40, Immenstadt, Germany|52, Jena, Germany|61, Jülich, Germany|44, Karlstadt, Germany|133, Kastellaun, Germany|125, Kaufbeuren, Germany|16, Kiel, Germany|99, Kleve, Germany|37, Krefeld, Germany|176, Köln, Germany|180, Köln, Germany|46, Lappersdorf, Germany|113, Leipzig, Germany|4, Leipzig, Germany|68, Leipzig, Germany|81, Leipzig, Germany|138, Lohr am Main, Germany|131, Ludwigsburg, Germany|148, Lüdenscheid, Germany|33, Mainz, Germany|154, Mannheim, Germany|151, Mühlhausen, Germany|101, München, Germany|167, München, Germany|2, München, Germany|43, Neuburg, Germany|62, Neukirchen-Vluyn, Germany|123, Neumarkt, Germany|69, Nürnberg, Germany|80, Oelde, Germany|98, Oldenburg, Germany|87, Oranienburg, Germany|57, Potsdam, Germany|3, Radeberg, Germany|159, Rathenow, Germany|45, Ravensburg, Germany|95, Rostock, Germany|85, Rüsselsheim, Germany|20, Schleswig, Germany|157, Schlüchtern, Germany|166, Schorndorf, Germany|181, Schriesheim, Germany|168, Schwedt, Germany|150, Schwäb. Gmünd, Germany|140, Senftenberg, Germany|164, Siegen, Germany|144, Sondershausen, Germany|127, Stralsund, Germany|14, Stuttgart, Germany|170, Stuttgart, Germany|104, Traunstein, Germany|183, Troisdorf, Germany|17, Tübingen, Germany|13, Ulm, Germany|48, Ulm, Germany|54, Unterhaching, Germany|171, Wermsdorf, Germany|143, Westerstede, Germany|79, Wismar, Germany|169, Wolfratshausen, Germany"
NCT00367432,A Long Term Follow up Administration Study of L059 (Levetiracetam) in Epilepsy Patients With Partial Onset Seizures,https://clinicaltrials.gov/study/NCT00367432,YES,Epilepsies|Partial,DRUG: Levetiracetam,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"Aichi-gun, Aichi, Japan|Nagoya, Aichi, Japan|Hirosaki, Aomori, Japan|Matsudo, Chiba, Japan|Kitakyusyu, Fukuoka, Japan|Koga, Fukuoka, Japan|Kurume, Fukuoka, Japan|Fukuyama, Hiroshima, Japan|Asahikawa, Hokkaido, Japan|Hakodate, Hokkaido, Japan|Sapporo, Hokkaido, Japan|Kobe, Hyogo, Japan|Kahoku-gun, Ishikawa, Japan|Kanazawa, Ishikawa, Japan|Zentsuji, Kagawa, Japan|Koshi, Kumamoto, Japan|Tsu, Mie, Japan|Iwanuma, Miyagi, Japan|Sendai, Miyagi, Japan|Omura, Nagasaki, Japan|Kashihara, Nara, Japan|Nagaoka, Niigata, Japan|Beppu, Oita, Japan|Izumi, Osaka, Japan|Neyagawa, Osaka, Japan|Suita, Osaka, Japan|Takatsuki, Osaka, Japan|Iruma-gun, Saitama, Japan|Shimotsuga-gun, Tochigi, Japan|Shimotsuke, Tochigi, Japan|Komatsushima, Tokushima, Japan|Chiyoda-Ku, Tokyo, Japan|Kodaira, Tokyo, Japan|Kokubunji, Tokyo, Japan|Shinjuku-ku, Tokyo, Japan|Taito-ku, Tokyo, Japan|Ube, Yamaguchi, Japan|Aomori, Japan|Chiba, Japan|Fukuoka, Japan|Fukushima, Japan|Gifu, Japan|Hiroshima, Japan|Kagoshima, Japan|Kumamoto, Japan|Kyoto, Japan|Miyazaki, Japan|Niigata, Japan|Okayama, Japan|Osaka, Japan|Shizuoka, Japan|Toyama, Japan|Yamagata, Japan"
NCT03559673,Compassionate Use Program With Lacosamide in Patients With Partial-onset or Generalized Tonic-clonic Seizures,https://clinicaltrials.gov/study/NCT03559673,NO,"Epilepsies, Partial",DRUG: Lacosamide,ALL,"CHILD, ADULT, OLDER_ADULT",,
NCT01441401,Safety and Efficacy of Gabapen for Pediatric (Regulatory Post Marketing Commitment Plan),https://clinicaltrials.gov/study/NCT01441401,YES,"Epilepsies, Partial",DRUG: gabapentin,ALL,CHILD,,
NCT06007053,Retraining and Control Therapy (ReACT) R33 Phase,https://clinicaltrials.gov/study/NCT06007053,NO,"Convulsion, Non-Epileptic",BEHAVIORAL: ReACT|BEHAVIORAL: Supportive Therapy,ALL,"CHILD, ADULT",NA,"University of Alabama at Birmingham, Birmingham, Alabama, 35294, United States"
NCT00422110,A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures,https://clinicaltrials.gov/study/NCT00422110,NO,"Epilepsies, Partial",DRUG: Seletracetam,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2|PHASE3,
NCT03024827,Cannabidiol in Children With Refractory Epileptic Encephalopathy,https://clinicaltrials.gov/study/NCT03024827,NO,Epileptic Encephalopathy,DRUG: CanniMed® 1:20,ALL,CHILD,PHASE1,"University of British Columbia, Vancouver, British Columbia, V6T1Z4, Canada|University of Manitoba, Winnipeg, Manitoba, R3T 2N2, Canada|Universite de Montreal, Montreal, Quebec, H3T1J4, Canada|University of Saskatchewan, Saskatoon, Saskatchewan, S7N5C5, Canada"
NCT05096273,Retraining and Control Therapy (ReACT): Sense of Control and Symptom Expectations as Targets of a Treatment for PNES,https://clinicaltrials.gov/study/NCT05096273,NO,"Convulsion, Non-Epileptic",BEHAVIORAL: ReACT,ALL,"CHILD, ADULT",NA,"Sparks Center Office of Psychiatric Research, Birmingham, Alabama, 35294, United States"
NCT03857074,Effects of Green Light Exposure on Epileptic Spikes in Patients With Refractory Epilepsy,https://clinicaltrials.gov/study/NCT03857074,NO,Epilepsy|Epilepsy Intractable,DEVICE: Green Light Exposure,ALL,"CHILD, ADULT",NA,"Boston Children's Hospital, Boston, Massachusetts, 02130, United States"
NCT00772603,Evaluation of Efficacy and Safety of OXC XR as Adjunctive Therapy for Partial Seizures,https://clinicaltrials.gov/study/NCT00772603,YES,"Epilepsies, Partial",DRUG: Placebo|DRUG: 2400mg SPN-804|DRUG: 1200mg SPN-804,ALL,"ADULT, OLDER_ADULT",PHASE3,"Huntsville, Alabama, United States|Northport, Alabama, United States|Phoenix, Arizona, United States|Tucson, Arizona, United States|Little Rock, Arkansas, United States|Riverside, California, United States|West Los Angeles, California, United States|Aurora, Colorado, United States|Jacksonville, Florida, United States|Miami, Florida, United States|Sarasota, Florida, United States|Atlanta, Georgia, United States|Springfield, Illinois, United States|Lexington, Kentucky, United States|Bethesda, Maryland, United States|Missoula, Montana, United States|Camden, New Jersey, United States|New York, New York, United States|Oklahoma City, Oklahoma, United States|Philadelphia, Pennsylvania, United States|Nashville, Tennessee, United States|Baytown, Texas, United States|Temple, Texas, United States|Blagoevgrad, Bulgaria|Pleven, Bulgaria|Plovdiv, Bulgaria|Ruse, Bulgaria|Sofia, Bulgaria|Varna, Bulgaria|Edmonton, Alberta, Canada|Greenfield Park, Quebec, Canada|Dubrovnik, Croatia|Rijeka, Croatia|Zadar, Croatia|Zagreb, Croatia|Ciudad Juárez, Chihuahua, Mexico|Mexico City, DF, Mexico|Toluca, Estado de Mexico, Mexico|Guadalajara, Jalisco, Mexico|Zapopan, Jalisco, Mexico|Monterrey, Nuevo Leon, Mexico|San Luis Potosi, San Luis Potosí, Mexico|Aguascalientes, Mexico|Chihuahua, Mexico|Durango, Mexico|Puebla, Mexico|Gizycko, Poland|Katowice, Poland|Konskie, Poland|Krakow, Poland|Lodz, Poland|Lublin, Poland|Warszawa, Poland|Wilkowice, Poland|Zabrze, Poland|Bucharest, Romania|Campulung Muscel, Romania|Cluj-Napoca, Romania|Craiova, Romania|St Petersburg, Sestroretsk, Russian Federation|Kazan, Russian Federation|Kirov, Russian Federation|Kursk, Russian Federation|Moscow, Russian Federation|Nizhniy Novgorod, Russian Federation|Nizhny Novgorod, Russian Federation|Novosibirsk, Russian Federation|Pyatigorsk, Russian Federation|Samara, Russian Federation|Smolensk, Russian Federation|St Petersburg, Russian Federation|St. Petersburg, Russian Federation|Yaroslavl, Russian Federation"
NCT02603991,Prospective Cohort Study on the Efficacy of Vagus Nerve Stimulation for Children and Adolescents With Epilepsy(PVNS-CAE),https://clinicaltrials.gov/study/NCT02603991,NO,Epileptic Encephalopathy,PROCEDURE: PINS Vagus Nerve Stimulator|DRUG: Levetiracetam,ALL,"CHILD, ADULT",,"Beijing Tiantan Hospital, Beijing, Beijing, 100050, China"
NCT00297323,An Observational Study of the Safety of Topiramate in Adults and Children With Epilepsy,https://clinicaltrials.gov/study/NCT00297323,NO,"Seizures, Epileptic",DRUG: Topiramate,ALL,"CHILD, ADULT, OLDER_ADULT",,
NCT05865561,Identification of Volatile Organic Compounds (VOCs) as Biopredictors of Epileptic Seizures,https://clinicaltrials.gov/study/NCT05865561,NO,Epilepsy,OTHER: VOC sampling,ALL,"ADULT, OLDER_ADULT",,
NCT02801136,Treatment Outcomes of ReACT for PNES,https://clinicaltrials.gov/study/NCT02801136,NO,"Convulsion, Non-Epileptic",BEHAVIORAL: ReACT|BEHAVIORAL: Supportive Therapy,ALL,"CHILD, ADULT",NA,"Sparks Center Office of Psychiatric Research, Birmingham, Alabama, 35294, United States"
NCT00522275,Determine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures,https://clinicaltrials.gov/study/NCT00522275,YES,Partial Epilepsies,DRUG: lacosamide,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"Birmingham, Alabama, United States|Mobile, Alabama, United States|Phoenix, Arizona, United States|Little Rock, Arkansas, United States|Los Angeles, California, United States|San Francisco, California, United States|Englewood, Colorado, United States|Fairfield, Connecticut, United States|Bradenton, Florida, United States|Jacksonville, Florida, United States|Maitland, Florida, United States|Saint Petersburg, Florida, United States|Tallahassee, Florida, United States|Tampa, Florida, United States|Atlanta, Georgia, United States|Chicago, Illinois, United States|Springfield, Illinois, United States|Indianapolis, Indiana, United States|Wichita, Kansas, United States|Lexington, Kentucky, United States|Louisville, Kentucky, United States|Baltimore, Maryland, United States|Bethesda, Maryland, United States|Boston, Massachusetts, United States|Golden Valley, Minnesota, United States|Saint Cloud, Minnesota, United States|Saint Paul, Minnesota, United States|Chesterfield, Missouri, United States|Somerset, New Jersey, United States|Albuquerque, New Mexico, United States|Buffalo, New York, United States|New York, New York, United States|Rochester, New York, United States|Syracuse, New York, United States|Asheville, North Carolina, United States|Durham, North Carolina, United States|Greenville, North Carolina, United States|Winston-Salem, North Carolina, United States|Cincinnati, Ohio, United States|Cleveland, Ohio, United States|Columbus, Ohio, United States|Toledo, Ohio, United States|Tulsa, Oklahoma, United States|Medford, Oregon, United States|Hershey, Pennsylvania, United States|Philadelphia, Pennsylvania, United States|Providence, Rhode Island, United States|Beaufort, South Carolina, United States|Charleston, South Carolina, United States|Nashville, Tennessee, United States|Dallas, Texas, United States|San Antonio, Texas, United States|Charlottesville, Virginia, United States|Newport News, Virginia, United States|Norfolk, Virginia, United States|Richmond, Virginia, United States|Seattle, Washington, United States|Morgantown, West Virginia, United States|Marshfield, Wisconsin, United States|Milwaukee, Wisconsin, United States"
NCT00524030,Efficacy And Safety Study Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial Seizures,https://clinicaltrials.gov/study/NCT00524030,YES,"Epilepsies, Partial",DRUG: pregabalin 600 mg/day|DRUG: pregabalin 150 mg/day,ALL,"ADULT, OLDER_ADULT",PHASE3,"Pfizer Investigational Site, Northport, Alabama, 35476, United States|Pfizer Investigational Site, Phoenix, Arizona, 85003, United States|Pfizer Investigational Site, Phoenix, Arizona, 85013, United States|Pfizer Investigational Site, Sun City, Arizona, 85351, United States|Pfizer Investigational Site, Fayetteville, Arkansas, 72703, United States|Pfizer Investigational Site, Fullerton, California, 92835, United States|Pfizer Investigational Site, Long Beach, California, 90806, United States|Pfizer Investigational Site, Modesto, California, 95355, United States|Pfizer Investigational Site, Murrieta, California, 92562, United States|Pfizer Investigational Site, Newport Beach, California, 92660, United States|Pfizer Investigational Site, Temecula, California, 92591, United States|Pfizer Investigational Site, Denver, Colorado, 80204, United States|Pfizer Investigational Site, Jacksonville, Florida, 32209, United States|Pfizer Investigational Site, Melbourne, Florida, 32901, United States|Pfizer Investigational Site, Miami, Florida, 33126, United States|Pfizer Investigational Site, Miami, Florida, 33136, United States|Pfizer Investigational Site, Sarasota, Florida, 34232, United States|Pfizer Investigational Site, Sarasota, Florida, 34233, United States|Pfizer Investigational Site, Atlanta, Georgia, 30309, United States|Pfizer Investigational Site, Atlanta, Georgia, 30342, United States|Pfizer Investigational Site, Decatur, Georgia, 30033, United States|Pfizer Investigational Site, Lawrenceville, Georgia, 30045, United States|Pfizer Investigational Site, Suwanee, Georgia, 30024, United States|Pfizer Investigational Site, Anderson, Indiana, 46016, United States|Pfizer Investigational Site, Danville, Indiana, 46122, United States|Pfizer Investigational Site, Fort Wayne, Indiana, 46805, United States|Pfizer Investigational Site, Kansas City, Kansas, 66160, United States|Pfizer Investigational Site, Bowling Green, Kentucky, 42101, United States|Pfizer Investigational Site, Lexington, Kentucky, 40536-0284, United States|Pfizer Investigational Site, Lexington, Kentucky, 40536, United States|Pfizer Investigational Site, Houma, Louisiana, 70363, United States|Pfizer Investigational Site, Shreveport, Louisiana, 71105-5634, United States|Pfizer Investigational Site, Pikesville, Maryland, 21208, United States|Pfizer Investigational Site, Worcester, Massachusetts, 01605, United States|Pfizer Investigational Site, Worcester, Massachusetts, 01608, United States|Pfizer Investigational Site, Detroit, Michigan, 48202, United States|Pfizer Investigational Site, Minneapolis, Minnesota, 55422, United States|Pfizer Investigational Site, Flowood, Mississippi, 39232, United States|Pfizer Investigational Site, Hattiesburg, Mississippi, 39401-7246, United States|Pfizer Investigational Site, Great Falls, Montana, 59405, United States|Pfizer Investigational Site, Cedarhurst, New York, 11516, United States|Pfizer Investigational Site, Charlotte, North Carolina, 28207, United States|Pfizer Investigational Site, Charlotte, North Carolina, 28209, United States|Pfizer Investigational Site, Rocky Mount, North Carolina, 27804, United States|Pfizer Investigational Site, Cleveland, Ohio, 44195, United States|Pfizer Investigational Site, Columbus, Ohio, 43210-1250, United States|Pfizer Investigational Site, Columbus, Ohio, 43210, United States|Pfizer Investigational Site, Oklahoma City, Oklahoma, 73112, United States|Pfizer Investigational Site, Oklahoma City, Oklahoma, 73120, United States|Pfizer Investigational Site, Altoona, Pennsylvania, 16602, United States|Pfizer Investigational Site, Indiana, Pennsylvania, 15701, United States|Pfizer Investigational Site, Philadelphia, Pennsylvania, 19140, United States|Pfizer Investigational Site, Memphis, Tennessee, 38120, United States|Pfizer Investigational Site, Memphis, Tennessee, 38163, United States|Pfizer Investigational Site, Nashville, Tennessee, 37232, United States|Pfizer Investigational Site, Dallas, Texas, 75230, United States|Pfizer Investigational Site, Houston, Texas, 77074-2906, United States|Pfizer Investigational Site, San Antonio, Texas, 78258, United States|Pfizer Investigational Site, Temple, Texas, 76508, United States|Pfizer Investigational Site, Murray, Utah, 84107, United States|Pfizer Investigational Site, Salt Lake City, Utah, 84107, United States|Pfizer Investigational Site, West Jordan, Utah, 84088, United States|Pfizer Investigational Site, Milwaukee, Wisconsin, 53226, United States|Pfizer Investigational Site, Beroun, 266 01, Czechia|Pfizer Investigational Site, Brno 2, 602 00, Czechia|Pfizer Investigational Site, Litomysl, 570 14, Czechia|Pfizer Investigational Site, New Territories, Hong Kong|Pfizer Investigational Site, Dnipropetrovsk, 49027, Ukraine|Pfizer Investigational Site, Dnipropetrovsk, 49115, Ukraine|Pfizer Investigational Site, Kharkiv, 61018, Ukraine|Pfizer Investigational Site, Kharkiv, 61068, Ukraine|Pfizer Investigational Site, Lugansk, 91045, Ukraine|Pfizer Investigational Site, Odessa, 65025, Ukraine"
NCT00215215,Effectiveness Study Comparing Treatment With Drug(s) or Adjunctive VNS Therapy for Pharmacoresistant Partial Seizures,https://clinicaltrials.gov/study/NCT00215215,NO,"Epilepsies, Partial",DEVICE: Vagus Nerve Stimulation Therapy,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,"Bronislav Shafran, M.D., P.C., Phoenix, Arizona, 85003, United States|Xenoscience, Phoenix, Arizona, 85013, United States|Dedicated Clinical Research, Inc., Sun City, Arizona, 85351, United States|USC Comprehensive Epilepsy Center, Los Angeles, California, 90033, United States|Certified Clinical Research, Roseville, California, 95661, United States|Pediatric Diagnostic Center, Ventura, California, 93003, United States|University of Florida, Department of Neurology, Gainesville, Florida, 32610, United States|Neurology Associates, P.A., Maitland, Florida, 32751, United States|Child Neurology Center of Northwest Florida, Pensacola, Florida, 32504, United States|Pediatric Neurology of Idaho, Boise, Idaho, 83712, United States|Freeport Health Network, Department of Neurology, Freeport, Illinois, 61032, United States|Wayne State University School of Medicine, Department of Neurology, Detroit, Michigan, 48201, United States|Weill-Cornell Medical College, N.Y. Presbyterian Hospital, Comprehensive Epilepsy Center, New York, New York, 10021, United States|William Huffstutter, M.D., Asheville, North Carolina, 28801, United States|Medford Neurological and Spine Clinic, Medford, Oregon, 997504, United States|Neurology and Sleep Medicine, Bethlehem, Pennsylvania, 18015, United States|Mid-South Physicians Group, P.L.L.C., Germantown, Tennessee, 38138, United States|Hermann Hospital, UT Comprehensive Epilepsy Center, Houston, Texas, 77030, United States|Texas Tech University Health Sciences Center, Lubbock, Texas, 79430, United States|Texas Association of Pediatric Neurology, San Antonio, Texas, 78258, United States|Pivotal Research Centers, Midvale, Utah, 84047, United States|Pharmaceutical Research Organization, South Ogden, Utah, 84403, United States|Regional Epilepsy Center Saint Luke's Medical Center, Milwaukee, Wisconsin, 53215, United States"
NCT00437281,"Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures",https://clinicaltrials.gov/study/NCT00437281,YES,"Epilepsies, Partial",DRUG: Placebo|DRUG: Pregabalin,ALL,CHILD,PHASE1|PHASE2,"Pfizer Investigational Site, Mobile, Alabama, 36604, United States|Pfizer Investigational Site, Mobile, Alabama, 36693, United States|Pfizer Investigational Site, Phoenix, Arizona, 85016, United States|Pfizer Investigational Site, Jonesboro, Arkansas, 72401, United States|Pfizer Investigational Site, Little Rock, Arkansas, 72205, United States|Pfizer Investigational Site, San Francisco, California, 94143, United States|Pfizer Investigational Site, Gulf Breeze, Florida, 32561, United States|Pfizer Investigational Site, Pensacola, Florida, 32504, United States|Pfizer Investigational Site, Tampa, Florida, 33603, United States|Pfizer Investigational Site, Tampa, Florida, 33609, United States|Pfizer Investigational Site, Springfield, Missouri, 65804, United States|Pfizer Investigational Site, Buffalo, New York, 14222, United States|Pfizer Investigational Site, Durham, North Carolina, 27710, United States|Pfizer Investigational Site, Houston, Texas, 77030, United States|Pfizer Investigational Site, San Antonio, Texas, 78258, United States|Pfizer Investigational Site, Seoul, 120-752, Korea, Republic of|Pfizer Investigational Site, Mexico, DF, 06720, Mexico|Pfizer Investigational Site, Guadalajara, Jalisco, 44280, Mexico"
NCT01764516,Study on Serum Zinc and Selenium Levels in Epileptic Patients,https://clinicaltrials.gov/study/NCT01764516,NO,Generalized Epileptic,,ALL,ADULT,,"Vali-Asr Hospital, Arak, Central province, Iran, Islamic Republic of"
NCT00620555,A Phase III Open-Label Extension Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures,https://clinicaltrials.gov/study/NCT00620555,YES,"Epilepsies, Partial",DRUG: gabapentin,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"Pfizer Investigational Site, Obu-shi,Morioka-machi, Aichi, Japan|Pfizer Investigational Site, Jonan-ku, Fukuoka, Japan|Pfizer Investigational Site, Kobe, Hyogo, Japan|Pfizer Investigational Site, Suma-Ku,Kobe, Hyogo, Japan|Pfizer Investigational Site, Kanazawa, Ishikawa, Japan|Pfizer Investigational Site, Zentsuuji, Kagawa, Japan|Pfizer Investigational Site, Yokohama, Kanagawa Pref., Japan|Pfizer Investigational Site, Sendai-shi, Miyagi-ken, Japan|Pfizer Investigational Site, Showa-Ku, Nagoya, Japan|Pfizer Investigational Site, Niigata-shi, Niigata, Japan|Pfizer Investigational Site, Kurashiki-City, Okayama Pref., Japan|Pfizer Investigational Site, Okayama-shi, Okayama, Japan|Pfizer Investigational Site, Izumi-shi, Osaka, Japan|Pfizer Investigational Site, Miyakojima-ku, Osaka, Japan|Pfizer Investigational Site, Suita, Osaka, Japan|Pfizer Investigational Site, Shizuoka-shi, Shizuoka, Japan|Pfizer Investigational Site, Kodaira, Tokyo, Japan|Pfizer Investigational Site, Setagaya-ku, Tokyo, Japan|Pfizer Investigational Site, Shinjuku-ku, Tokyo, Japan|Pfizer Investigational Site, Hiroshima, Japan|Pfizer Investigational Site, Saitama, Japan|Pfizer Investigational Site, Yamagata, Japan"
NCT00448916,Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures,https://clinicaltrials.gov/study/NCT00448916,YES,"Epilepsies, Partial",DRUG: Pregabalin,ALL,CHILD,PHASE3,"University of South Alabama, Mobile, Alabama, 36604, United States|University of South Alabama Department of Neurology, Mobile, Alabama, 36693, United States|Phoenix Children's Hospital, Phoenix, Arizona, 85016, United States|The Children's Clinica of Jonesboro, P.A, Jonesboro, Arkansas, 72401, United States|Clinical Study Centers, L. L. C., Little Rock, Arkansas, 72205, United States|UCSF Neurology Clinic, San Francisco, California, 94143, United States|Child Neurology Center of Northwest Florida, Gulf Breeze, Florida, 32561, United States|The Office of Sergio J Jacinto, MD, Tampa, Florida, 33603, United States|Pediatric Epilepsy & Neurology Specialists, Tampa, Florida, 33609, United States|St. John's Clinic, Springfield, Missouri, 65804, United States|St. John's Hospital, Springfield, Missouri, 65804, United States|Women and Children's Hospital of Buffalo, Buffalo, New York, 14222, United States|Duke University Medical Center, Durham, North Carolina, 27710, United States|Baylor College of Medicine - Texas Children's Hospital, Houston, Texas, 77030, United States|Texas Children's Hospital, Houston, Texas, 77030, United States|Road Runner Research, Ltd., San Antonio, Texas, 78258, United States|Yonsei University College of Medicine Severance Hospital / Department of Pediatric Neurology, Seoul, 120-752, Korea, Republic of|Antiguo Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, 44280, Mexico"
NCT00351611,Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo,https://clinicaltrials.gov/study/NCT00351611,YES,"Epilepsies, Partial",DRUG: Lyrica (pregabalin)|DRUG: placebo,ALL,"ADULT, OLDER_ADULT",PHASE4,"Neurology Center, P.C., Mobile, Alabama, 36607, United States|Premier Medical Group, Mobile, Alabama, 36608, United States|Neurology Clinic, PC, Northport, Alabama, 35476, United States|North River Ophthalmology, Tuscaloosa, Alabama, 35406, United States|Western Neurosurgery, Tucson, Arizona, 85710, United States|Office of Robert Snyder, MD, Tucson, Arizona, 85712, United States|REM Medical Clinical Research, Tucson, Arizona, 85712, United States|NEA Baptist Clinic - Clinical Research Center, Jonesboro, Arkansas, 72401, United States|NEA Baptist Clinic, Jonesboro, Arkansas, 72401, United States|NEA Baptst Clinic, Jonesboro, Arkansas, 72401, United States|Chenal MRI, Little Rock, Arkansas, 72205, United States|Clinical Trials, Inc., Little Rock, Arkansas, 72205, United States|Eye Care Arkansas, Little Rock, Arkansas, 72205, United States|Radiology Consultants, Little Rock, Arkansas, 72205, United States|University of Arkansas for Medical Sciences, Little Rock, Arkansas, 72205, United States|Barbara Swartz, MD, Inc, Costa Mesa, California, 92627, United States|Mireille P. Hamparian, Glendale, California, 91206, United States|Lakeside Vision Center, Irvine, California, 92604, United States|Eye Treatment Center, Inc., Long Beach, California, 90813, United States|Hoag Memorial Hospital Presbyterian, Newport Beach, California, 92658, United States|Clinical Innovations, Inc., Paramount, California, 90723, United States|Yale University School of Medicine, New Haven, Connecticut, 06520-8018, United States|Bradenton Research Center, Inc, Bradenton, Florida, 34205, United States|The Eye Associates, Bradenton, Florida, 34209, United States|SJS Clinical Research, Inc., Destin, Florida, 32541, United States|White Wilson Medical Center, Fort Walton Beach, Florida, 32547, United States|Pharmax Research Clinic, Inc., Miami, Florida, 33126, United States|Dr. Raul F. Masvidal, MD, PA, Miami, Florida, 33134, United States|David M Klein, MD, PA, Port Charlotte, Florida, 33948, United States|Medsol Clinical Research Center, Inc, Port Charlotte, Florida, 33952, United States|Intercoastal Medical Research Center, Sarasota, Florida, 34232, United States|Dr. Nicholas Monsul, Sarasota, Florida, 34239, United States|Sarasota Retinal Institute, Sarasota, Florida, 34239, United States|Coastal Research Associates, LLC, Atlanta, Georgia, 30339, United States|Comprehensive Neurology Specialists, PC, Suwanee, Georgia, 30024, United States|Professional Research Network of Kansas, Wichita, Kansas, 67203, United States|Vitreo-Retinal Consultants and Surgeons, Wichita, Kansas, 67214, United States|Neuromedical Clinic of Central Louisiana, Alexandria, Louisiana, 71301, United States|Louisiana Eye and Laser Center, Alexandria, Louisiana, 71303, United States|University of Maryland Eye Associates, P.A., Baltimore, Maryland, 21201, United States|University of Maryland School of Medicine, Baltimore, Maryland, 21201, United States|University of Maryland, Baltimore, Maryland, 21201, United States|Glaucoma Plus Eye Care, LLC, Columbia, Maryland, 21044, United States|Center for Brain and Neuro Care, LLC, Fulton, Maryland, 20759, United States|Bergman Eye Associates, Hagerstown, Maryland, 21740, United States|Neurology Consultant, P.A., Hagerstown, Maryland, 21740, United States|The Center for Clinical Research, Hagerstown, Maryland, 21740, United States|Harper Hospital, Detroit, Michigan, 48201, United States|Wayne State University, Detroit, Michigan, 48201, United States|Fraser Eye Care Center, Fraser, Michigan, 48026, United States|Minneapolis Clinic of Neurology, Ltd, Golden Valley, Minnesota, 55422, United States|University of Missouri, Columbia, Missouri, 65212, United States|CCN-MS & Neurology Associates, Columbia, Missouri, 65401, United States|Nevada Eye Care, Las Vegas, Nevada, 89119, United States|Neurology Center of Las Vegas, Las Vegas, Nevada, 89128, United States|Institute of Neurological Care, Englewood Cliffs, New Jersey, 07632, United States|Office of Patricia Burke, MD, Paramus, New Jersey, 07652, United States|Dent Neurologic Institute, Amherst, New York, 14226, United States|Dent Neurosciences Research Center, Amherst, New York, 14226, United States|Western New York Ophthalmology Group, Amherst, New York, 14226, United States|Buffalo General Hospital, Buffalo, New York, 14203, United States|The Jacobs Neurological Institute Comprehensive Epilepsy Center, Buffalo, New York, 14209, United States|Guilford Neurologic Associates, Inc, Greensboro, North Carolina, 27405, United States|Digby Eye Associates, Greensboro, North Carolina, 27408, United States|Clinical Research of Winston-Salem, Winston-Salem, North Carolina, 27103, United States|Salem Neurological Center, PA, Winston-Salem, North Carolina, 27103, United States|Office of Dr. James D. Branch, MD, Winston-Salem, North Carolina, 27107, United States|MetroHealth Medical Center, Cleveland, Ohio, 44109, United States|The Cleveland Clinic, Cleveland, Ohio, 44195, United States|The Ohio State University Medical Center, Columbus, Ohio, 43210, United States|Jeffrey Shaver, MD, Edmond, Oklahoma, 73013, United States|Sooner Clinical Research, Oklahoma City, Oklahoma, 73112, United States|Clinical Trials of America, Inc., Eugene, Oregon, 97401, United States|Oregon Eye Consultants, LLC, Eugene, Oregon, 97401, United States|Pacific Women's Center, LLC, Eugene, Oregon, 97401, United States|Oregon Neurology Associates, Springfield, Oregon, 97477, United States|Daniel J. Nadler, MD, PC, Beaver, Pennsylvania, 15009, United States|Heritage Valley Health System, Beaver, Pennsylvania, 15009, United States|Valley Neurological Associates, Monaca, Pennsylvania, 15061, United States|Center For Advanced Eye Care, Greenville, South Carolina, 29615, United States|Premier Neurology, PC, Greer, South Carolina, 29650, United States|Coastal Carolina Research Center, Mount Pleasant, South Carolina, 29464, United States|Glaucoma Consultants and Center for Eye Research, PA, Mount Pleasant, South Carolina, 29464, United States|Tidewater Neurology, Mount Pleasant, South Carolina, 29464, United States|Neurology Centers of the Carolinas, Spartanburg, South Carolina, 29302, United States|Piedmont Eye Associates, Spartanburg, South Carolina, 29303, United States|Envision Eye Care, Bristol, Tennessee, 37620, United States|Tri-state Mountain Neurology Associates, PC, Johnson City, Tennessee, 37604, United States|Semmes Murphey Clinic, Memphis, Tennessee, 38104, United States|Semmes Murphey Clinic, Memphis, Tennessee, 38120, United States|University of Tennessee Health Science Center, Memphis, Tennessee, 38163, United States|FutureSearch Trials of Neurology, Austin, Texas, 78731, United States|Texan Eye, Austin, Texas, 78731, United States|Texas Neurology, PA, Dallas, Texas, 75214, United States|Glaucoma Associates of Texas, Dallas, Texas, 75231, United States|Egret Bay Neurology, PA, Houston, Texas, 77058, United States|DeHaven Eye Clinic, Longview, Texas, 75601, United States|Diagnostic Clinic of Longview Center for Clinical Research, Longview, Texas, 75605, United States|Diagnostic Clinic of Longview, PA, Longview, Texas, 75605, United States|Coastal Eye Associates, Webster, Texas, 77598, United States|Neurological Associates Sarah Cannon Cancer Institute;, Richmond, Virginia, 23229, United States|Medical College of Wisconsin Department of Neurology Froedtert Memorial Hospital, Milwaukee, Wisconsin, 53226-3522, United States|Medical College of Wisconsin Eye Institute, Milwaukee, Wisconsin, 53226, United States|DKC 2, Sofia, 1000, Bulgaria|Chetvarta nevrologichna klinika, Sofia, 1113, Bulgaria|Otdelenie po Nevrologia, Vtora MBAL, Sofia, 1202, Bulgaria|Otdelenie po nevrologia, MBAL ""Tokuda Bolnitsa"", Sofia, 1407, Bulgaria|Universitetska mnogoprofilna bolnitsa za aktivno lechenieAleksandrovska, Klinika po Nevrologia, Sofia, 1431, Bulgaria|Otdelenie po nervni bolesti, MBAL Doverie, Sofia, 1632, Bulgaria|Fakultni Thomayerova nemocnice, Praha 4, 140 59, Czechia|NEUROPS s.r.o., Rychnov nad Kneznou, 516 01, Czechia|Ocni ambulance, Rychnov nad Kneznou, 516 01, Czechia|Synexus Kft., Budapest, 1036, Hungary|Budapest Retina Associates Kft., Budapest, 1133, Hungary|Orszagos Idegtudomanyi Intezet, Stroke es Epilepszia Osztaly, Budapest, 1145, Hungary|Orszagos Idegtudomanyi Intezet, Budapest, 1145, Hungary|Csongrad Megyei Egeszsegugyi Ellato Kozpont Hodmezovasarhely-Mako,, Hodmezovasarhely, 6800, Hungary|Netra Diagnostics (P) Ltd, Abids, Hyderabad, Andhra Pradesh, 500 001, India|Krishna Institute of Medical Sciences Ltd., Secunderabad, Andhra Pradesh, 500 003, India|King George Hospital, Visakhapatnam, Andhra Pradesh, 530002, India|M.S. Ramaiah Medical College and Hospitals,, Bangalore,, Karnataka, 560054, India|St. John's Medical College Hospital, Bangalore, Karnataka, 560034, India|Mallikatta Neuro Center, Mangalore, Karnataka, 575002, India|Kasturba Medical College and Hospital,, Manipal, Karnataka, 576 104, India|Eye Site,, Indore, Madhya Pradesh, 452 001, India|M.G.M. Medical College & M. Y. Hospitals,, Indore, Madhya Pradesh, 452 001, India|T.N.M.C and B.Y.L Nair Charitable Hospital,, Mumbai, Maharashtra, 400 008, India|Kelkar Nursing Home, Pune, Maharashtra, 411004, India|Sahyadri Clinical Research Development Centre, A unit of Sahyadri Hospitals Ltd,, Pune, Maharashtra, 411004, India|Sahyadri Speciality Hospital, Pune, Maharashtra, 411004, India|Vijaya Health Centre, Chennai, Tamil NADU, 600 026, India|Yashoda Hospital, Hyderabad, Telangana, 500 082, India|Dr. Ram Manohar Lohia Hospital, New Delhi, 110 001, India|All India Institute of Medical Sciences (AIIMS), New Delhi, 110029, India|Keimyung University Dongsan Hospital, Daegu, 41931, Korea, Republic of|Seoul National University Hospital, Seoul, 03080, Korea, Republic of|Yonsei University Health System Severance Hospital, Seoul, 03722, Korea, Republic of|Asan Medical Center, Seoul, 05505, Korea, Republic of|Samsung Medical Center, Seoul, 06351, Korea, Republic of|Instituto Biomedico de Investigacion AC, Aguascalientes, Aquascalientes, 20127, Mexico|Dr. Ruben Munoz Flores de la Torre Ophthalmic Office, Aquascalientes, 20000, Mexico|Hospital Central Dr. Ignacio Morones Prieto, San Luis Potosi, 78240, Mexico|Niepubliczny Zaklad Opieki Zdrowotnej ""OKOmed"" s.c., Goczalkowice Zdroj, 43-230, Poland|NZOZ Tommed, Katowice, 40-662, Poland|Centrum Medyczne Dendryt, Katowice, 40-683, Poland|Prywatny Gabinet Psychiatryczny dr Ewa Dereszak-Kozanecka, Krakow, 30-040, Poland|Prywatny Gabinet Okulistyczny dr. n.med. Teresa Gedliczka, Krakow, 30-319, Poland|NZOZ Centrum Leczenia Padaczki i Migreny, Krakow, 31-209, Poland|Khon Kaen University, Faculty of Medicine, Neurology Unit, Department of Medicine, Muang, Khon Kaen, 40002, Thailand|Phramongkutklao hospital,, Bangkok, 10400, Thailand"
NCT00567268,Drug Use Investigation Of Gabapentin,https://clinicaltrials.gov/study/NCT00567268,YES,"Epilepsies, Partial",DRUG: Gabapentin,ALL,"CHILD, ADULT, OLDER_ADULT",,
NCT00603473,A Phase III Open-Label Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures,https://clinicaltrials.gov/study/NCT00603473,YES,"Epilepsies, Partial",DRUG: gabapentin,ALL,CHILD,PHASE3,"Pfizer Investigational Site, Obu-shi,Morioka-machi, Aichi, Japan|Pfizer Investigational Site, Jonan-ku, Fukuoka, Japan|Pfizer Investigational Site, Sapporo, Hokkaido, Japan|Pfizer Investigational Site, Kobe, Hyogo, Japan|Pfizer Investigational Site, Suma-Ku, Kobe, Hyogo, Japan|Pfizer Investigational Site, Kanazawa, Ishikawa, Japan|Pfizer Investigational Site, Zentsuuji, Kagawa, Japan|Pfizer Investigational Site, Yokohama, Kanagawa Pref., Japan|Pfizer Investigational Site, Sendai-shi, Miyagi-ken, Japan|Pfizer Investigational Site, Showa-Ku, Nagoya, Japan|Pfizer Investigational Site, Niigata-shi, Niigata, Japan|Pfizer Investigational Site, Kurashiki-City, Okayama Pref., Japan|Pfizer Investigational Site, Okayama-shi, Okayama, Japan|Pfizer Investigational Site, Izumi-shi, Osaka, Japan|Pfizer Investigational Site, Miyakojima-ku, Osaka, Japan|Pfizer Investigational Site, Suita, Osaka, Japan|Pfizer Investigational Site, Higashimatsuyama, Saitama, Japan|Pfizer Investigational Site, Shizuoka-shi, Shizuoka, Japan|Pfizer Investigational Site, Kiyose-shi, Tokyo, Japan|Pfizer Investigational Site, Kodaira, Tokyo, Japan|Pfizer Investigational Site, Setagaya-ku, Tokyo, Japan|Pfizer Investigational Site, Shinjuku-ku, Tokyo, Japan|Pfizer Investigational Site, Hiroshima, Japan|Pfizer Investigational Site, Saitama, Japan|Pfizer Investigational Site, Yamagata, Japan|Pfizer Investigational Site, Yamanashi, Japan"
NCT00552305,To Determine Tolerability and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures,https://clinicaltrials.gov/study/NCT00552305,YES,Partial Epilepsies,DRUG: lacosamide,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,"Birmingham, Alabama, United States|Huntsville, Alabama, United States|Phoenix, Arizona, United States|Tucson, Arizona, United States|Little Rock, Arkansas, United States|Los Angeles, California, United States|Englewood, Colorado, United States|Gainesville, Florida, United States|Hollywood, Florida, United States|Miami, Florida, United States|Ponte Vedra Beach, Florida, United States|Chicago, Illinois, United States|Springfield, Illinois, United States|Indianapolis, Indiana, United States|Iowa City, Iowa, United States|Wichita, Kansas, United States|Crestview Hills, Kentucky, United States|Lexington, Kentucky, United States|Baltimore, Maryland, United States|Frederick, Maryland, United States|Boston, Massachusetts, United States|Ann Arbor, Michigan, United States|Detroit, Michigan, United States|Saint Paul, Minnesota, United States|Chesterfield, Missouri, United States|Saint Louis, Missouri, United States|Somerset, New Jersey, United States|New York, New York, United States|Durham, North Carolina, United States|Cincinnati, Ohio, United States|Cleveland, Ohio, United States|Columbus, Ohio, United States|Hershey, Pennsylvania, United States|Philadelphia, Pennsylvania, United States|Nashville, Tennessee, United States|Dallas, Texas, United States|Irving, Texas, United States|Lubbock, Texas, United States|Wichita Falls, Texas, United States|Bennington, Vermont, United States|Charlottesville, Virginia, United States|Marshfield, Wisconsin, United States|Milwaukee, Wisconsin, United States|Bonn, Germany|Erlangen, Germany|Kehl Kork, Germany|Schwalmstedt-Treysa, Germany|Budapest, Hungary|Zalaegerszeg, Hungary|Kaunas, Lithuania|Vilnius, Lithuania|Poznan, Poland|Goteborg, Sweden|Stockholm, Sweden|Bern/Biel, Switzerland|Zurich, Switzerland|Bucks/London, United Kingdom|Glasgow, United Kingdom|Liverpool, United Kingdom"
NCT04515316,A Room Temperature Atomic Magnetrode System for Telemetry of Epileptic Seizures,https://clinicaltrials.gov/study/NCT04515316,NO,Epilepsy,DEVICE: OPM sensors|DEVICE: SQUID sensors,ALL,"ADULT, OLDER_ADULT",NA,"University of Colorado School of Medicine - Anschutz Medical Campus, Aurora, Colorado, 80045, United States"
NCT05257915,A China RWS to Evaluate the Effectiveness and Safety of Perampanel as an add-on Treatment for Epileptic Seizure,https://clinicaltrials.gov/study/NCT05257915,NO,Epilepsy,DRUG: Perampanel,ALL,"CHILD, ADULT, OLDER_ADULT",,"Beijing Children's Hospital, Capital Medical University, Beijing, Beijing, 100045, China|Beijing TianTan Hospital, Capital Medical University, Beijing, Beijing, China|Beijing University First Hospital, Beijing, Beijing, China|Peking Union Medical College Hospital, Beijing, Beijing, China|Peking University People's Hospital, Beijing, Beijing, China"
NCT04102254,Thalamic Stimulation for Epilepsy Study,https://clinicaltrials.gov/study/NCT04102254,NO,Seizures|Epilepsy|Seizure Disorder,PROCEDURE: ANT recording and stimulation,ALL,"ADULT, OLDER_ADULT",NA,"Duke University Health System, Durham, North Carolina, 27710, United States"
NCT00151879,Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures,https://clinicaltrials.gov/study/NCT00151879,NO,"Epilepsies, Partial",DRUG: SPM 927,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2|PHASE3,"Schwarz, RTP, North Carolina, United States"
NCT05873062,"Safety, Blood Levels and Effects of AUT00201 in Patients With MEAK",https://clinicaltrials.gov/study/NCT05873062,NO,"Myoclonus Epilepsies, Progressive",DRUG: AUT00201|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE1,"University of Pennsylvania, Penn Epilepsy Center, Philadelphia, Pennsylvania, 19104, United States"
NCT05274035,A Multi-center RWS of Perampanel as an add-on Treatment for Epileptic Seizures in Chinese Children,https://clinicaltrials.gov/study/NCT05274035,NO,Epilepsy,DRUG: Perampanel,ALL,CHILD,,"Beijing Children's Hospital, Capital Medical University, Beijing, Beijing, 100045, China|Wuhan Children's Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, 430015, China|XuZhou Children's Hospital, XuZhou, Jiangsu, 221002, China|Jinan Children's Hospital, Jinan, Shandong, 250022, China|Tianjin Children's Hospital, Tianjin, Tianjin, 300134, China"
NCT06210022,Cognitive Impairment in Drug-resistant and Drug-responsive Focal Cryptogenic Epilepsy,https://clinicaltrials.gov/study/NCT06210022,NO,Epilepsy|Focal Epilepsy,DIAGNOSTIC_TEST: Neuropsychological Assessment,ALL,ADULT,,"IRCCS San Raffaele, Milan, 20132, Italy"
NCT02441478,Co-operative Behavior and Decision-making in Frontal Lobe Epilepsy,https://clinicaltrials.gov/study/NCT02441478,NO,Frontal Lobe Epilepsies,RADIATION: functional magnetic resonance imaging exam,ALL,ADULT,NA,"Hospices Civils de Lyon, Lyon, 69002, France"
NCT00210652,An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy,https://clinicaltrials.gov/study/NCT00210652,NO,"Epilepsy|Epilepsies, Partial",DRUG: RWJ 333369:,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,
NCT04457687,Extended Access Program With Lorcaserin For The Treatment of Dravet Syndrome and Other Refractory Epilepsies,https://clinicaltrials.gov/study/NCT04457687,NO,"Epilepsies, Myoclonic|Drug Resistant Epilepsy",DRUG: Lorcaserin,ALL,"CHILD, ADULT, OLDER_ADULT",,
NCT00210522,An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy,https://clinicaltrials.gov/study/NCT00210522,NO,"Epilepsy|Epilepsies, Partial",DRUG: RWJ 333369,ALL,"ADULT, OLDER_ADULT",PHASE2,
NCT05518578,Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy,https://clinicaltrials.gov/study/NCT05518578,NO,"Epilepsy|Seizures, Epileptic",DRUG: SPN-817,ALL,"ADULT, OLDER_ADULT",PHASE2,"Alfred Hospital, Melbourne, Australia"
NCT04284072,Clinical Scenarios for Long-term Monitoring of Epileptic Seizures With a Wearable Biopotential Technology,https://clinicaltrials.gov/study/NCT04284072,NO,Epilepsy,DEVICE: Sensor Dot,ALL,"CHILD, ADULT, OLDER_ADULT",NA,"University Hospitals Leuven, department of Neurology, Leuven, 3000, Belgium|Department of Epileptology and Neurology, Aachen, Germany|Epilepsy Center, University Medical Center, Freiburg University, Freiburg, Germany|Division of Neurology, Coimbra University Hospital, Coimbra, Portugal|Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden|Division of Neuroscience, King's College London, London, United Kingdom|Nuffield Department of Clinical Neurosciences, Oxford University Hospital, Oxford, United Kingdom"
NCT05066880,Yoga and Aerobic Exercise in Epilepsy,https://clinicaltrials.gov/study/NCT05066880,NO,Epilepsy|Epilepsy; Seizure|Epilepsy Idiopathic,OTHER: Exercise training,ALL,"ADULT, OLDER_ADULT",NA,"Dokuz Eylul University, Izmir, Turkey"
NCT00150293,Evaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.,https://clinicaltrials.gov/study/NCT00150293,NO,"Seizure Disorder, Partial",DRUG: Pregabalin,ALL,"ADULT, OLDER_ADULT",PHASE3,"Pfizer Investigational Site, Deakin, Australian Capital Territory, 2600, Australia|Pfizer Investigational Site, Camperdown, New South Wales, 2050, Australia|Pfizer Investigational Site, Chastwood, New South Wales, 2067, Australia|Pfizer Investigational Site, Cairns, Queensland, 4870, Australia|Pfizer Investigational Site, Maroochydore, Queensland, 4558, Australia|Pfizer Investigational Site, Footscray, Victoria, 3011, Australia|Pfizer Investigational Site, Parkville, Victoria, 3050, Australia|Pfizer Investigational Site, Perth, Western Australia, 6001, Australia|Pfizer Investigational Site, Auenbruggerplatz 22, A-8035 GRAZ, Austria|Pfizer Investigational Site, Graz, 8020, Austria|Pfizer Investigational Site, Innsbruck, A6020, Austria|Pfizer Investigational Site, Linz, 4020, Austria|Pfizer Investigational Site, Wien, 1220, Austria|Pfizer Investigational Site, Leuven, 3000, Belgium|Pfizer Investigational Site, Calgary, Alberta, T2N 2T9, Canada|Pfizer Investigational Site, Edmonton, Alberta, T5G 0B7, Canada|Pfizer Investigational Site, Penticton, British Columbia, V2A 4V8, Canada|Pfizer Investigational Site, Vancouver, British Columbia, V5Z 1M9, Canada|Pfizer Investigational Site, Halifax, Nova Scotia, B3H 3A7, Canada|Pfizer Investigational Site, Barrie, Ontario, L4M 4S5, Canada|Pfizer Investigational Site, London, Ontario, N6A 5A5, Canada|Pfizer Investigational Site, Ottawa, Ontario, K1L 8L6, Canada|Pfizer Investigational Site, Toronto, Ontario, M5T 2S8, Canada|Pfizer Investigational Site, Windsor, Ontario, N8X5A6, Canada|Pfizer Investigational Site, Montreal, Quebec, H1T 2M4, Canada|Pfizer Investigational Site, Montreal, Quebec, H2L 4M1, Canada|Pfizer Investigational Site, Montreal, Quebec, H3A 2B4, Canada|Pfizer Investigational Site, Regina, Saskatchewan, S4T 1A5, Canada|Pfizer Investigational Site, Saskatoon, Saskatchewan, S7N 0W8, Canada|Pfizer Investigational Site, Quebec, G1J 1Z4, Canada|Pfizer Investigational Site, Ulm, BW, 89081, Germany|Pfizer Investigational Site, Berlin, BE10362, Germany|Pfizer Investigational Site, Bernau, 16321, Germany|Pfizer Investigational Site, Bonn, 53127, Germany|Pfizer Investigational Site, Dresden, 01307, Germany|Pfizer Investigational Site, Erlangen, 91054, Germany|Pfizer Investigational Site, Essen, 45147, Germany|Pfizer Investigational Site, Frankfurt, HE 60528, Germany|Pfizer Investigational Site, Freiburg, 79106, Germany|Pfizer Investigational Site, Goettingen, D-37075, Germany|Pfizer Investigational Site, Hamburg, D-22337, Germany|Pfizer Investigational Site, Mainz, 55101, Germany|Pfizer Investigational Site, Muenchen, 81377, Germany|Pfizer Investigational Site, AE Breda, 4836, Netherlands|Pfizer Investigational Site, Blaricum, 1261 AN, Netherlands|Pfizer Investigational Site, Ve Heeze, 5591, Netherlands|Pfizer Investigational Site, Bialystok, 15-276, Poland|Pfizer Investigational Site, Bydgoszcz, 85-826, Poland|Pfizer Investigational Site, Choroszcz, 16-070, Poland|Pfizer Investigational Site, Gdansk, 80-211, Poland|Pfizer Investigational Site, Gdansk, 82-803, Poland|Pfizer Investigational Site, Grudziadz, 86-300, Poland|Pfizer Investigational Site, Katowice, 46-645, Poland|Pfizer Investigational Site, Krakow, 31-112, Poland|Pfizer Investigational Site, Lublin, 20-718, Poland|Pfizer Investigational Site, Mosina, 62-050, Poland|Pfizer Investigational Site, Olsztyn, 10-561, Poland|Pfizer Investigational Site, Plock, 09-402, Poland|Pfizer Investigational Site, Poznan, 60-780, Poland|Pfizer Investigational Site, Poznan, 61-285, Poland|Pfizer Investigational Site, Torun, 87-100, Poland|Pfizer Investigational Site, Warsaw, 00-909, Poland|Pfizer Investigational Site, Warsaw, 02-957, Poland|Pfizer Investigational Site, Warszawa, 00-909, Poland|Pfizer Investigational Site, Warszawa, Poland|Pfizer Investigational Site, Coimbra, 3000-075, Portugal|Pfizer Investigational Site, Porto, 4099, Portugal|Pfizer Investigational Site, Barcelona, 08036, Spain|Pfizer Investigational Site, Girona, 17007, Spain|Pfizer Investigational Site, Granada, 18013, Spain|Pfizer Investigational Site, Madrid, 28034, Spain|Pfizer Investigational Site, Madrid, 28040, Spain|Pfizer Investigational Site, Malaga, 29010, Spain|Pfizer Investigational Site, Zaragoza, 50009, Spain|Pfizer Investigational Site, Middlesborough, N. York, TS5 5AZ, United Kingdom|Pfizer Investigational Site, Washington, Tyne & Wear, NE38 9JZ, United Kingdom|Pfizer Investigational Site, Blackpool, FY3 8BP, United Kingdom|Pfizer Investigational Site, Dundee, DD1 9SY, United Kingdom|Pfizer Investigational Site, Glasgow, G11 6NT, United Kingdom|Pfizer Investigational Site, Leeds, LS9 7TF, United Kingdom|Pfizer Investigational Site, London, E1 1BB, United Kingdom|Pfizer Investigational Site, Northampton, NN1 5BD, United Kingdom|Pfizer Investigational Site, Wolverhampton, WV10 0QP, United Kingdom|Pfizer Investigational Site"
NCT00141388,To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures,https://clinicaltrials.gov/study/NCT00141388,NO,"Seizure Disorder, Partial",DRUG: Pregabalin,ALL,"ADULT, OLDER_ADULT",PHASE3,"Pfizer Investigational Site, Birmingham, Alabama, 35249, United States|Pfizer Investigational Site, Birmingham, Alabama, 35255, United States|Pfizer Investigational Site, Birmingham, Alabama, 35294-0021, United States|Pfizer Investigational Site, Phoenix, Arizona, 85006, United States|Pfizer Investigational Site, Tucson, Arizona, 85712-2809, United States|Pfizer Investigational Site, Tucson, Arizona, 85712, United States|Pfizer Investigational Site, Little Rock, Arkansas, 72205, United States|Pfizer Investigational Site, Los Angeles, California, 90033, United States|Pfizer Investigational Site, Pasadena, California, 91105, United States|Pfizer Investigational Site, Gainesville, Florida, 32608-1197, United States|Pfizer Investigational Site, Gainesville, Florida, 32610, United States|Pfizer Investigational Site, Miami, Florida, 33136, United States|Pfizer Investigational Site, Plantation, Florida, 33317, United States|Pfizer Investigational Site, Spring Hill, Florida, 34609, United States|Pfizer Investigational Site, Tallahassee, Florida, 32308, United States|Pfizer Investigational Site, Chicago, Illinois, 60612, United States|Pfizer Investigational Site, Springfield, Illinois, 62702, United States|Pfizer Investigational Site, Springfield, Illinois, 62704, United States|Pfizer Investigational Site, Indianapolis, Indiana, 46202, United States|Pfizer Investigational Site, Indianapolis, Indiana, 46254, United States|Pfizer Investigational Site, Iowa City, Iowa, 52242, United States|Pfizer Investigational Site, Kansas City, Kansas, 66160-7314, United States|Pfizer Investigational Site, Kansas City, Kansas, 66160, United States|Pfizer Investigational Site, Louisville, Kentucky, 40205, United States|Pfizer Investigational Site, Baltimore, Maryland, 21201, United States|Pfizer Investigational Site, Baltimore, Maryland, 21224, United States|Pfizer Investigational Site, Greenbelt, Maryland, 20770, United States|Pfizer Investigational Site, Boston, Massachusetts, 02130, United States|Pfizer Investigational Site, Boston, Massachusetts, 02215, United States|Pfizer Investigational Site, Ann Arbor, Michigan, 48108, United States|Pfizer Investigational Site, Ann Arbor, Michigan, 48109, United States|Pfizer Investigational Site, St. Paul, Minnesota, 55102, United States|Pfizer Investigational Site, Chesterfield, Missouri, 63017, United States|Pfizer Investigational Site, Columbia, Missouri, 65212, United States|Pfizer Investigational Site, St. Louis, Missouri, 63110-1092, United States|Pfizer Investigational Site, St. Louis, Missouri, 63110, United States|Pfizer Investigational Site, Lebanon, New Hampshire, 03756, United States|Pfizer Investigational Site, New York, New York, 10016, United States|Pfizer Investigational Site, New York, New York, 10032, United States|Pfizer Investigational Site, Rochester, New York, 14642, United States|Pfizer Investigational Site, Winston-Salem, North Carolina, 27157, United States|Pfizer Investigational Site, Cleveland, Ohio, 44195, United States|Pfizer Investigational Site, Columbus, Ohio, 43210, United States|Pfizer Investigational Site, Portland, Oregon, 97227, United States|Pfizer Investigational Site, Nashville, Tennessee, 37232, United States|Pfizer Investigational Site, Dallas, Texas, 75230, United States|Pfizer Investigational Site, San Antonio, Texas, 78229, United States|Pfizer Investigational Site, Bennington, Vermont, 05201, United States|Pfizer Investigational Site, Edmonton, Alberta, T5H 3V9, Canada|Pfizer Investigational Site, Edmont, Alberta, T5G 0B7, Canada|Pfizer Investigational Site, Vancouver, British Columbia, V52 1M9, Canada|Pfizer Investigational Site, Vancouver, British Columbia, V67 1Y6, Canada|Pfizer Investigational Site, London, Ontario, N6A 5A5, Canada|Pfizer Investigational Site, Ottawa, Ontario, K1H 8L6, Canada|Pfizer Investigational Site, Toronto, Ontario, M4Y 1J3, Canada|Pfizer Investigational Site, Montreal, Quebec, H3A 2B4, Canada"
NCT00141336,To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.,https://clinicaltrials.gov/study/NCT00141336,NO,"Seizure Disorder, Partial",DRUG: Pregabalin,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"Pfizer Investigational Site, Phoenix, Arizona, 85013, United States|Pfizer Investigational Site, Tucson, Arizona, 85724, United States|Pfizer Investigational Site, Bakersfield, California, 93301, United States|Pfizer Investigational Site, Berkeley, California, 94705, United States|Pfizer Investigational Site, Concord, California, 94520, United States|Pfizer Investigational Site, Covina, California, 91723, United States|Pfizer Investigational Site, El Cajon, California, 92021, United States|Pfizer Investigational Site, Encino, California, 91436, United States|Pfizer Investigational Site, La Mesa, California, 91942, United States|Pfizer Investigational Site, Marina del Ray, California, 90292, United States|Pfizer Investigational Site, Martinez, California, 94553, United States|Pfizer Investigational Site, Northridge, California, 91325, United States|Pfizer Investigational Site, Pinole, California, 94564, United States|Pfizer Investigational Site, Redondo Beach, California, 90277, United States|Pfizer Investigational Site, Sacramento, California, 95816, United States|Pfizer Investigational Site, Sacramento, California, 95823, United States|Pfizer Investigational Site, San Diego, California, 92120, United States|Pfizer Investigational Site, Santa Monica, California, 90404, United States|Pfizer Investigational Site, Walnut Creek, California, 94598, United States|Pfizer Investigational Site, Denver, Colorado, 80218, United States|Pfizer Investigational Site, Englewood, Colorado, 80110, United States|Pfizer Investigational Site, Danbury, Connecticut, 06810, United States|Pfizer Investigational Site, Miami, Florida, 33173, United States|Pfizer Investigational Site, Miami, Florida, 33176, United States|Pfizer Investigational Site, Orlando, Florida, 32806, United States|Pfizer Investigational Site, Tampa, Florida, 33609, United States|Pfizer Investigational Site, Atlanta, Georgia, 30322, United States|Pfizer Investigational Site, Chicago, Illinois, 60611, United States|Pfizer Investigational Site, Chicago, Illinois, 60612, United States|Pfizer Investigational Site, Chicago, Illinois, 60640, United States|Pfizer Investigational Site, Crestview Hills, Kentucky, 41017, United States|Pfizer Investigational Site, Louisville, Kentucky, 40202, United States|Pfizer Investigational Site, Ruston, Louisiana, 71270, United States|Pfizer Investigational Site, Baltimore, Maryland, 21287, United States|Pfizer Investigational Site, Detroit, Michigan, 48202-2689, United States|Pfizer Investigational Site, Golden Valley, Minnesota, 55422, United States|Pfizer Investigational Site, Minneapolis, Minnesota, 55422, United States|Pfizer Investigational Site, Jackson, Mississippi, 39216, United States|Pfizer Investigational Site, St. Louis, Missouri, 63110, United States|Pfizer Investigational Site, Las Vegas, Nevada, 89102, United States|Pfizer Investigational Site, Las Vegas, Nevada, 89106, United States|Pfizer Investigational Site, Concord, New Hampshire, 03301, United States|Pfizer Investigational Site, Dover, New Hampshire, 03820, United States|Pfizer Investigational Site, New Brunswick, New Jersey, 08901, United States|Pfizer Investigational Site, New Brunswick, New Jersey, 08903, United States|Pfizer Investigational Site, Ridgewood, New Jersey, 07450, United States|Pfizer Investigational Site, Albuquerque, New Mexico, 87131-5021, United States|Pfizer Investigational Site, Albuquerque, New Mexico, 87131-5281, United States|Pfizer Investigational Site, Albuquerque, New Mexico, 87131, United States|Pfizer Investigational Site, Bronx, New York, 10467, United States|Pfizer Investigational Site, Brooklyn, New York, 11203, United States|Pfizer Investigational Site, New York, New York, 10021, United States|Pfizer Investigational Site, Asheville, North Carolina, 28803, United States|Pfizer Investigational Site, Asheville, North Carolina, 28806, United States|Pfizer Investigational Site, Raleigh, North Carolina, 27607, United States|Pfizer Investigational Site, Winston-Salem, North Carolina, 27103, United States|Pfizer Investigational Site, Winston-Salem, North Carolina, 37103, United States|Pfizer Investigational Site, Cincinnati, Ohio, 45219, United States|Pfizer Investigational Site, Cincinnati, Ohio, 45242, United States|Pfizer Investigational Site, Columbus, Ohio, 43210, United States|Pfizer Investigational Site, Oklahoma City, Oklahoma, 73104-5068, United States|Pfizer Investigational Site, Medford, Oregon, 97504, United States|Pfizer Investigational Site, Portland, Oregon, 97201, United States|Pfizer Investigational Site, Portland, Oregon, 97209, United States|Pfizer Investigational Site, Portland, Oregon, 97210, United States|Pfizer Investigational Site, Philadelphia, Pennsylvania, 19104, United States|Pfizer Investigational Site, Philadelphia, Pennsylvania, 19107, United States|Pfizer Investigational Site, Pittsburgh, Pennsylvania, 15212, United States|Pfizer Investigational Site, Ridley Park, Pennsylvania, 19078, United States|Pfizer Investigational Site, Upland, Pennsylvania, 19013, United States|Pfizer Investigational Site, Cranston, Rhode Island, 02920, United States|Pfizer Investigational Site, Knoxville, Tennessee, 37916, United States|Pfizer Investigational Site, Memphis, Tennessee, 38103, United States|Pfizer Investigational Site, Dallas, Texas, 75216, United States|Pfizer Investigational Site, Dallas, Texas, 75230, United States|Pfizer Investigational Site, Dallas, Texas, 75243, United States|Pfizer Investigational Site, Fort Worth, Texas, 76107-2699, United States|Pfizer Investigational Site, Fort Worth, Texas, 76107, United States|Pfizer Investigational Site, Houston, Texas, 77002, United States|Pfizer Investigational Site, Houston, Texas, 77025, United States|Pfizer Investigational Site, Houston, Texas, 77030, United States|Pfizer Investigational Site, Lubbock, Texas, 79410, United States|Pfizer Investigational Site, San Antonio, Texas, 78207, United States|Pfizer Investigational Site, San Antonio, Texas, 78229, United States|Pfizer Investigational Site, Alexandria, Virginia, 22304, United States|Pfizer Investigational Site, Alexandria, Virginia, 22311, United States|Pfizer Investigational Site, Charlottesville, Virginia, 22908, United States|Pfizer Investigational Site, Roanoke, Virginia, 24014, United States|Pfizer Investigational Site, Roanoke, Virginia, 24016, United States|Pfizer Investigational Site, Sterling, Virginia, 20165, United States|Pfizer Investigational Site, Bellevue, Washington, 98004, United States|Pfizer Investigational Site, Bellvue, Washington, 98004, United States|Pfizer Investigational Site, Spokane, Washington, 99202, United States|Pfizer Investigational Site, Spokane, Washington, 99204, United States|Pfizer Investigational Site, Morgantown, West Virginia, 26507, United States|Pfizer Investigational Site, Marshfield, Wisconsin, 54449, United States|Pfizer Investigational Site, Milwaukee, Wisconsin, 53226, United States|Pfizer Investigational Site, Calgary, Alberta, T2N 2T9, Canada|Pfizer Investigational Site, Edmonton, Alberta, T5G 0B7, Canada|Pfizer Investigational Site, Edmonton, Alberta, T5H 3V9, Canada|Pfizer Investigational Site, Barrie, Ontario, L4M 4S5, Canada|Pfizer Investigational Site, London, Ontario, N6A 5A5, Canada|Pfizer Investigational Site, Toronto, Ontario, M5C 1R6, Canada"
NCT00141245,To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.,https://clinicaltrials.gov/study/NCT00141245,NO,"Seizure Disorder, Partial",DRUG: Pregabalin,ALL,"ADULT, OLDER_ADULT",PHASE3,"Pfizer Investigational Site, Deakin, Australian Capital Territory, 2600, Australia|Pfizer Investigational Site, Chatswood, New South Wales, 2067, Australia|Pfizer Investigational Site, Westmead, New South Wales, 2145, Australia|Pfizer Investigational Site, Maroochydore, Queensland, 4558, Australia|Pfizer Investigational Site, Heidelberg, VIC 3084, Australia|Pfizer Investigational Site, Woodville, 5011, Australia|Pfizer Investigational Site, Graz, A-8035, Austria|Pfizer Investigational Site, Innsbruck, A-6020, Austria|Pfizer Investigational Site, Duffel, 2570, Belgium|Pfizer Investigational Site, Helsinki, 00029, Finland|Pfizer Investigational Site, Turku, FIN-20521, Finland|Pfizer Investigational Site, Lyon, Cedex, 69694, France|Pfizer Investigational Site, Paris, Cedex, 75674, France|Pfizer Investigational Site, Tours, Cedex, 37044, France|Pfizer Investigational Site, Dijon, 21000, France|Pfizer Investigational Site, Paris Cedex 13, 75651, France|Pfizer Investigational Site, Roubaix, 59100, France|Pfizer Investigational Site, Erlangen, 91054, Germany|Pfizer Investigational Site, Freiburg, 79106, Germany|Pfizer Investigational Site, Goettingen, D-37075, Germany|Pfizer Investigational Site, Hamburg, 22292, Germany|Pfizer Investigational Site, Mainz, 55131, Germany|Pfizer Investigational Site, Moenchengladbach, 41179, Germany|Pfizer Investigational Site, Muenster, 48149, Germany|Pfizer Investigational Site, Munich, D-81377, Germany|Pfizer Investigational Site, Firenze, 50135, Italy|Pfizer Investigational Site, Pavia, 27100, Italy|Pfizer Investigational Site, Perugia, 06123, Italy|Pfizer Investigational Site, Pisa, 56126, Italy|Pfizer Investigational Site, Heemstede, 2103 SW, Netherlands|Pfizer Investigational Site, Heeze, 5591 VE, Netherlands|Pfizer Investigational Site, Parow, Cape Town, 7505, South Africa|Pfizer Investigational Site, Durban, 4052, South Africa|Pfizer Investigational Site, San Sebastian, Guipuzcoa, 20014, Spain|Pfizer Investigational Site, Barcelona, 08036, Spain|Pfizer Investigational Site, Gerona, 17007, Spain|Pfizer Investigational Site, Sevilla, 41013, Spain|Pfizer Investigational Site, Goteborg, S-413 45, Sweden|Pfizer Investigational Site, Lavigny, LE, CN-1775, Switzerland|Pfizer Investigational Site, Tschugg, CH-3233, Switzerland|Pfizer Investigational Site, Bimingham, B15 2QZ, United Kingdom|Pfizer Investigational Site, Bucks, SL9 ORJ, United Kingdom|Pfizer Investigational Site, Dundee, DD1 9ND, United Kingdom|Pfizer Investigational Site, Glasgow, G11 6NT, United Kingdom|Pfizer Investigational Site, Liverpool, L9 1AE, United Kingdom|Pfizer Investigational Site, York, Y03 7HE, United Kingdom"
NCT02286271,Preliminary Testing of a Novel Device to Detect Epileptic Seizures,https://clinicaltrials.gov/study/NCT02286271,NO,Epilepsy,,ALL,"CHILD, ADULT, OLDER_ADULT",,"Western General Hospital, Edinburgh, EH4 2XU, United Kingdom|Royal Hospital for Sick Children, Edinburgh, EH9 1LF, United Kingdom"
NCT00067431,A Study of the Safety and Efficacy of Depakote Sprinkle Capsules in the Treatment of Partial Seizures in Children,https://clinicaltrials.gov/study/NCT00067431,NO,Partial Seizure Disorder,DRUG: Divalproex Sodium (Depakote® Sprinkle Capsules),ALL,CHILD,PHASE3,"Pediatric Epilepsy & Neurology Specialist, Tampa, Florida, 33607, United States|Rainbow Babies Children's Hospital, Cleveland, Ohio, 44106, United States|University Hospital of Cleveland, Cleveland, Ohio, United States|PCTI / Children's Hospital, Columbus, Ohio, 43205, United States|Primary Physician's Research, Pittsburgh, Pennsylvania, United States|Texas Association of Pediatric Neurology, PA, San Antonio, Texas, 78258, United States|Virginia Commonwealth University, Richmond, Virginia, 23298-0211, United States"
NCT03949478,Treating Postictal Symptoms Using Ibuprofen and Nifedipine,https://clinicaltrials.gov/study/NCT03949478,NO,"Epilepsy|Epilepsies, Partial",DRUG: Ibuprofen|DRUG: Nifedipine|DRUG: Placebo,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,"Foothills Medical Centre, Calgary, Alberta, T2N T29, Canada|South Health Campus, Calgary, Alberta, T3M 1M4, Canada"
NCT04291716,Study to Validate Novel Seizure-Detection Algorithm,https://clinicaltrials.gov/study/NCT04291716,NO,"Seizures, Motor|Seizures|Seizure Disorder|Epilepsy|Epileptic Seizures|Epileptic",DEVICE: Motor Seizure Detection Algorithm (mSDA),ALL,"ADULT, OLDER_ADULT",NA,"Covenant Hospital and Covenant Medical Group, Lubbock, Texas, 79410, United States"
NCT00050934,Pediatric Epilepsy Study,https://clinicaltrials.gov/study/NCT00050934,NO,"Epilepsy|Epilepsies, Partial",DRUG: oxcarbazepine,ALL,CHILD,PHASE3,"Birmingham, Alabama, 35233, United States|Mobile, Alabama, 36693, United States|Los Angeles, California, 90027, United States|Los Angeles, California, 90095, United States|Madera, California, 93638, United States|Orange, California, 92868, United States|Wilmington, Delaware, 19806, United States|Miami, Florida, 33155, United States|Tampa, Florida, 33607, United States|Atlanta, Georgia, 30342, United States|Boise, Idaho, 83712, United States|Ann Arbor, Michigan, 48109, United States|Duluth, Minnesota, 55805, United States|St. Paul, Minnesota, 55102, United States|Chesterfields, Missouri, 63017, United States|Buffalo, New York, 14222, United States|New York, New York, 10016, United States|New York, New York, 10032, United States|Akron, Ohio, 44308, United States|Cincinnati, Ohio, 45229, United States|Cleveland, Ohio, 44106, United States|Portland, Oregon, 97201, United States|Philadelphia, Pennsylvania, 19104, United States|Fort Worth, Texas, 76104, United States|Houston, Texas, 77030, United States|Norfolk, Virginia, 23507, United States|Brigadeiro Hospital, Sao Paulo - SP, 01401-901, Brazil|Kehl-Kork, 77694, Germany|Kiel, 24105, Germany|Novartis, Mexico City, Mexico"
NCT01657084,Stopping and Preventing Epileptic Seizures Using a Partial Rebreathing Mask,https://clinicaltrials.gov/study/NCT01657084,NO,Epilepsy,DEVICE: CDA Mask|DEVICE: Dummy mask,ALL,"ADULT, OLDER_ADULT",NA,"Aarhus University Hospital, Aarhus, 8000, Denmark|The Epilepsy Hospital Filadelfia, Dianalund, Denmark"
NCT06366009,Assessment of Patients With Drug-resistant Temporal Lobe Epilepsy With EEG Extended With Intra-auricular Electrodes,https://clinicaltrials.gov/study/NCT06366009,NO,Epilepsy|Focal Epilepsy|Drug Resistant Epilepsy,DEVICE: NaoX in-ear EEG system,ALL,"ADULT, OLDER_ADULT",,"Kliniki Neurochirurgii CSK UCK WUM, Warsaw, Poland"
NCT03643016,Improving EPilepsy Surgery Management and progNOsis Using Virtual Epileptic Patient Software (VEP),https://clinicaltrials.gov/study/NCT03643016,NO,Epilepsy,OTHER: Surgical strategy based on a software,ALL,"CHILD, ADULT, OLDER_ADULT",NA,"Assistance Publique Hopitaux de Marseille, Marseille, 13354, France"
NCT04649008,Localizing Epileptic Networks Using MRI and iEEG,https://clinicaltrials.gov/study/NCT04649008,NO,"Epilepsy|Epilepsy Intractable|Epilepsy, Temporal Lobe",DIAGNOSTIC_TEST: 3T Magnetic Resonance Imaging|DIAGNOSTIC_TEST: Intracranial electroencephalography recordings|DIAGNOSTIC_TEST: 7T Magnetic Resonance Imaging,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,"University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States"
NCT03551431,Comparison of Efficacy Between Suggestion Method During Video EEG Recording by Verbal Suggestion in Isolation and Verbal Suggestion Along With Cotton Swab or Tuning Fork for Inducing the Paroxysmal Event in Children Aged 5 to 18 Years With Suspected Psychogenic Nonepileptic Events,https://clinicaltrials.gov/study/NCT03551431,NO,"EEG, Psychogenic Non Epileptic Events",DIAGNOSTIC_TEST: Video EEG with verbal suggestion,ALL,"CHILD, ADULT",NA,
NCT01311440,Modified Atkins Diet Treatment for Adults With Drug-resistant Epilepsy,https://clinicaltrials.gov/study/NCT01311440,NO,Epilepsy|Focal Epilepsy|Generalized Epilepsy,OTHER: Modified Atkins diet treatment,ALL,"CHILD, ADULT, OLDER_ADULT",NA,"Oslo University Hospital, The national Centre for epilepsy, Sandvika, Bærum Postterminal, 1306, Norway"
NCT05844696,Electrical Neuromodulation for Focal Epilepsy,https://clinicaltrials.gov/study/NCT05844696,NO,Epilepsy,DEVICE: Soterix MXN-5 HD-tES Model 5005A. Medtronic Percept DBS platform.,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,
NCT03403907,The Effect of Probiotic Supplementation in Drug-resistant Epilepsy Patients,https://clinicaltrials.gov/study/NCT03403907,NO,Epilepsy|Epilepsy Intractable,OTHER: Probiotic,ALL,"ADULT, OLDER_ADULT",NA,
NCT05285059,Implicit Learning in Epileptic Children,https://clinicaltrials.gov/study/NCT05285059,NO,Epilepsy,BEHAVIORAL: ASRT task,ALL,CHILD,,"Agathe Marcastel, PhD, Bron, 69675, France|Dezso Nemeth, Bron, 69675, France|Service d'Epileptologie Clinique, des Troubles du sommeil et de Neurologie fonctionnelle de l'enfant, à Hôpital Femme Mère et Enfant,, Bron, France"
NCT03013348,Automated Identification of Psychogenic Nonepileptic Seizures,https://clinicaltrials.gov/study/NCT03013348,NO,"Convulsion, Non-Epileptic",DEVICE: Brain Sentinel's sEMG Post-processing algorithm,ALL,"CHILD, ADULT, OLDER_ADULT",,
NCT04158531,REC2Stim as a Treatment for Refractory Epilepsy in the Primary Sensorimotor Cortex.,https://clinicaltrials.gov/study/NCT04158531,NO,Epileptic Seizure|Epilepsy Intractable|Motor Seizure,DEVICE: ECoG sensing and stimulation,ALL,"CHILD, ADULT, OLDER_ADULT",NA,"University Medical Center Utrecht, Utrecht, 3584 CX, Netherlands"
NCT04607317,Exercise as Adjunctive Treatment for Refractory Epilepsy,https://clinicaltrials.gov/study/NCT04607317,NO,Refractory Epilepsy|Epilepsy,BEHAVIORAL: Exercise program|BEHAVIORAL: Health Coach|BEHAVIORAL: Health Information,ALL,"ADULT, OLDER_ADULT",NA,"Wake Forest University Health Sciences, Winston-Salem, North Carolina, 27157, United States"
NCT00282854,Genetics of Rolandic Epilepsy,https://clinicaltrials.gov/study/NCT00282854,NO,Epilepsy,,ALL,"CHILD, ADULT, OLDER_ADULT",,"Mailman School of Public Health, Columbia University Medical Center, 722 West 168th St, 6th Floor, New York, New York, 10032, United States"
NCT00236730,A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control Epilepsy,https://clinicaltrials.gov/study/NCT00236730,NO,"Epilepsy|Epilepsies, Partial|Seizures",DRUG: topiramate,ALL,"ADULT, OLDER_ADULT",PHASE2,
NCT05776745,Study of Speech Function in Epileptic Patients Based on Stereoelectroencephalography Signal,https://clinicaltrials.gov/study/NCT05776745,NO,Epilepsy,BEHAVIORAL: Speech|DEVICE: Stereoelectroencephalography,ALL,"CHILD, ADULT",NA,"Zhejiang University School of Medicine Second Affiliated Hospital, Hangzhou, Zhejiang, 310009, China"
NCT02682927,A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome,https://clinicaltrials.gov/study/NCT02682927,YES,Dravet Syndrome|Seizure Disorder,DRUG: ZX008 (Fenfluramine Hydrochloride)|DRUG: Matching Placebo,ALL,"CHILD, ADULT",PHASE3,"Phoenix Children's, Phoenix, Arizona, 85016, United States|Center for Neurosciences - Tucson, Tucson, Arizona, 85718, United States|Rady Children's Hospital San Diego, San Diego, California, 92123, United States|University of California San Francisco, San Francisco, California, 94143, United States|The Children's Hospital Colorado, Aurora, Colorado, 80045, United States|NW FL Clinical Research Group, LLC, Gulf Breeze, Florida, 32561, United States|Miami Children's Hospital Brain Institute, Miami, Florida, 33155, United States|Neurology and Epilepsy Research Center, Orlando, Florida, 32819, United States|Panda Neurology, Atlanta, Georgia, 30328, United States|Children's Hospital of Chicago, Chicago, Illinois, 60611, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Boston Children's Hospital, Boston, Massachusetts, 02467, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|Saint Barnabas Medical Center, Livingston, New Jersey, 07039, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States|Cook Children's Medical Center, Fort Worth, Texas, 76087, United States|University of Utah, Salt Lake City, Utah, 84113, United States|Seattle Children's Hospital, Seattle, Washington, 98105, United States|MultiCare Institute for Research & Innovation, Tacoma, Washington, 98405, United States|Melbourne Brain Centre Austin Hospital, Melbourne, Australia|Children's Health Queensland Hospital and Health Service at Lady Cilento Children's Hospital, South Brisbane, Australia|The Children's Hospital Westmead Dept. of Neurology and Neurosurgery, Westmead, Australia|Universitair Ziekenhuis Antwerpen, Antwerp, Belgium|British Columbia Children's Hospital BCCH, Vancouver, British Columbia, V6H3V4, Canada|Centre Hospitalier Universitaire Sainte-Justine, Montréal, H3T 1C5, Canada|Danish National Epilepsy Centre, Dianalund, Denmark|French Ref centre Necker Hospital Paris, Paris, France|Epilepsiezentrum / Neuropädiatrie Hedwig-von-Rittberg-Zentrum Für Kinder und Jugendliche, Berlin, Germany|Krankenhaus Mara Epilepsie-Zentrum Bethel, Bielefeld, Germany|Epilepsiezentrum Freiburg, Freiburg, Germany|Universitaetsklinikum Jena Klinik fuer Kinder- und Jugendmedizin Neuropaediatrie, Jena, Germany|Klinik für Neuropädiatrie Universitätsklinikum Schleswig Holstein Campus Kiel, Kiel, Germany|Kleinwachau Saechsisches Epilepsiezentrum Radeberggemeinnuetzige GmbH, Radeberg, Germany|Universitaetsklinik fuer Kinder- und Jugendmedizin Abteilung III, Tübingen, Germany|Schoen Klinik Vogtareuth Neuropaediatrie und Neurologische Rehabilitation, Epilepsiezentrum fuer Kinder und Jugendlische,Tagesklinik fuer Neuropaediatrie, Vogtareuth, Germany|AOU Anna Meyer, Firenze, 50139, Italy|Istituto Pediatrico Giannina Gaslini Dipartimento di Neurologia, Genova, Italy|A.O Carlo Poma, Mantova, 46100, Italy|Instituto Neurologica Carlo Besta, Milano, 20133, Italy|Ospedale Fatebenefratelli e Oftalmico, Milano, Italy|U.O. Neurologia Dipartimento di Neuroscienze Ospedale Pediatrico Bambino Gesù, IRCS, Roma, 00165, Italy|Ospedal Policlinico Giambattista Rossi diBorga Roma, Verona, 37134, Italy|Okayama University Hospital, Okayama-shi, Okayama, Japan|Saitama Children's Medical Center, Saitama-shi, Saitama, Japan|National Epilepsy Center Shizuoka Institute, Shizuoka-city, Shizuoka, Japan|Tokyo Women's Medical University Hospital, Shinjuku-ku, Tokyo, Japan|Hospital Sant Joande Déu, Barcelona, Spain|Hospital Ruber Internacional Primera Planta Servicio de Neurologia, Madrid, Spain|Clinica Universitaria de Navarra Fase 4. Segunda planta, Consulta de Pediatria, Pamplona, Spain|Birmingham Children Hospital, Birmingham, United Kingdom|Institute of Neurosciences Queens Elizabeth University Hospital, Glasgow, United Kingdom|Alder Hey Hospital, Liverpool, United Kingdom|Evelina Hospital, London, United Kingdom|Great Ormonnd Street Hospital for Children NHS Foundation Trust, London, United Kingdom|Sheffield Children's Hospital, Sheffield, United Kingdom"
NCT05015868,"Contribution of Genetics, Non-invasive Methods and Neuropsychology in Focal Cryptogenic Epilepsies",https://clinicaltrials.gov/study/NCT05015868,NO,"Epilepsies, Partial|Epilepsy Intractable",DIAGNOSTIC_TEST: Standard of care|DIAGNOSTIC_TEST: Functional magnetic resonance imaging-Electroencephalogram combined analysis|DIAGNOSTIC_TEST: High density- electroencephalogram or 7 Tesla magnetic resonance imaging,ALL,"CHILD, ADULT",NA,"Scientific Institute IRCCS Eugenio Medea, Bosisio Parini, Lecco, 23842, Italy"
NCT00236691,"A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.",https://clinicaltrials.gov/study/NCT00236691,NO,"Epilepsy|Epilepsies, Partial|Seizures",DRUG: topiramate,ALL,"ADULT, OLDER_ADULT",PHASE2,
NCT00236873,"A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.",https://clinicaltrials.gov/study/NCT00236873,NO,"Epilepsy|Epilepsies, Partial|Seizures",DRUG: topiramate,ALL,"ADULT, OLDER_ADULT",PHASE2,
NCT00236860,"A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures",https://clinicaltrials.gov/study/NCT00236860,NO,"Epilepsy|Epilepsies, Partial|Seizures",DRUG: topiramate,ALL,"ADULT, OLDER_ADULT",PHASE2,
NCT05561166,EPIDREAM 1 : Study of Dreaming in Epilepsy,https://clinicaltrials.gov/study/NCT05561166,NO,Epilepsy,OTHER: EPIDREAM Questionnaire,ALL,"ADULT, OLDER_ADULT",,"Hospices Civils de Lyon, Bron, Rhône, 69500, France"
NCT04716673,Stimulation of Sleep in Patients With Epilepsy,https://clinicaltrials.gov/study/NCT04716673,NO,Epilepsy,OTHER: Down-phase targeted auditory stimulation,ALL,"CHILD, ADULT",NA,"University Children's Hospital Zurich, Zurich, 8032, Switzerland"
NCT05269901,Association Between Ferroptosis and Epilepsy,https://clinicaltrials.gov/study/NCT05269901,NO,Epilepsy,"GENETIC: SLC7A11, GPX4, P53",ALL,CHILD,,"Affiliated Hospital of JiangNan University, Department of Pediatrics, Wuxi, Jiangsu, 226600, China"
NCT05671575,Study The Knowledge and Attitude Towards Epilepsy Among Relatives of People With Epilepsy and Their Impact on The Patient's Quality of Life,https://clinicaltrials.gov/study/NCT05671575,NO,Epilepsy,OTHER: Questionnaire about Epilepsy,ALL,"CHILD, ADULT, OLDER_ADULT",,"Sohag university hospital, Sohag, 82611, Egypt"
NCT05450822,Precision Medicine in the Treatment of Epilepsy,https://clinicaltrials.gov/study/NCT05450822,NO,Epilepsy,DRUG: Levetiracetam|DRUG: Levetiracetam Tablets|DRUG: Lamotrigine tablet,ALL,"CHILD, ADULT",,"Neurobiology Research Unit, Rigshospitalet, Copenhagen, 2100, Denmark"
NCT05698537,Risk Factors and Etiologies of Epilepsy in Urban and Rural Rwanda,https://clinicaltrials.gov/study/NCT05698537,NO,Epilepsy,DIAGNOSTIC_TEST: EEG|DIAGNOSTIC_TEST: Neuroimaging|DIAGNOSTIC_TEST: Blood sample|OTHER: Risk factor questionnaire,ALL,"CHILD, ADULT, OLDER_ADULT",,"King Faisal Hospital, Kigali, Rwanda"
NCT04266990,Olfactive Discriminative Ability of Dogs When Confronted With Seizure and Non-seizure Samples // Identification of Potential Biomarkers for Epilepsy in Human Sweat.,https://clinicaltrials.gov/study/NCT04266990,NO,Epilepsy,OTHER: Planned Sweat collection|OTHER: Spontaneous Sweat collection|OTHER: Healthy volunteers sweat collection,ALL,"ADULT, OLDER_ADULT",NA,"UZ Gent, Gent, Belgie, 9000, Belgium"
NCT04526418,Evaluation of the 24/7 EEG SubQ System for Ultra Long-Term Recording of Patients With Temporal Lobe Epilepsy,https://clinicaltrials.gov/study/NCT04526418,NO,Epilepsy,DEVICE: 24/7 EEG™ SubQ system,ALL,"ADULT, OLDER_ADULT",NA,"Mayo Clinic, Phoenix, Arizona, 85054, United States|University of California, Los Angeles, California, 90095, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|University of Pennsylvenia, Philadelphia, Pennsylvania, 19104, United States|Universität Klinikum Freibrug, Freiburg, 79106, Germany|Walton Centre NHS Foundation Trust, Fazakerley, Liverpool, L9 7LJ, United Kingdom"
NCT04705441,Self-management for People With Epilepsy,https://clinicaltrials.gov/study/NCT04705441,NO,Epilepsy,BEHAVIORAL: SMART 2,ALL,"ADULT, OLDER_ADULT",NA,"University of Iowa, Iowa City, Iowa, 52242, United States|Case Western Reserve University, Cleveland, Ohio, 44106, United States"
NCT03582345,Investigation of Human Epileptic Networks by fMRI,https://clinicaltrials.gov/study/NCT03582345,NO,Epilepsy,PROCEDURE: EEG/fMRI,ALL,"ADULT, OLDER_ADULT",NA,
NCT05934786,Rehabilitation of Cognition and Psychosocial Well-being in Epilepsy,https://clinicaltrials.gov/study/NCT05934786,NO,Epilepsy,BEHAVIORAL: Cognitive rehabilitation,ALL,"ADULT, OLDER_ADULT",NA,
NCT05082181,Telephone-Based Support Programs for People With Epilepsy,https://clinicaltrials.gov/study/NCT05082181,NO,Epilepsy,BEHAVIORAL: UPLIFT (Using Practice and Learning to Increase Favorable Thoughts)|BEHAVIORAL: BOOST (Bringing Out Our Strength Together),ALL,"ADULT, OLDER_ADULT",NA,"NYU Langone Health, New York, New York, 10016, United States"
NCT05683847,User Controlled Follow-up of Epilepsy,https://clinicaltrials.gov/study/NCT05683847,NO,Epilepsy,OTHER: User controlled epilepsy follow-up by means of patient reported outcome measures (PROM),ALL,"ADULT, OLDER_ADULT",,"Drammen Hospital, Drammen, 3004, Norway"
NCT05384782,Computational Decision Support in Epilepsy Using Retrospective EEG,https://clinicaltrials.gov/study/NCT05384782,NO,Epilepsy,,ALL,"ADULT, OLDER_ADULT",,"Cornwall Partnership NHS Foundation Trust, Bodmin, Cornwall, PL31 2QN, United Kingdom"
NCT00236847,A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy.,https://clinicaltrials.gov/study/NCT00236847,NO,"Epilepsy|Epilepsies, Partial|Seizures",DRUG: topiramate,ALL,"ADULT, OLDER_ADULT",PHASE2,
NCT05898438,The Role of Gut Microbiota in Children With Epilepsy Following Ketogenic Diet,https://clinicaltrials.gov/study/NCT05898438,NO,Epilepsy,,ALL,"CHILD, ADULT",,"Attikon Athens University Hospital, Athens, Haidari, 12462, Greece"
NCT06139198,Self-management Intervention for Reducing Epilepsy Burden Among Ugandans With Epilepsy.,https://clinicaltrials.gov/study/NCT06139198,NO,Epilepsy,BEHAVIORAL: Self-MAnagement intervention for Reducing The epilepsy burden among Ugandans,ALL,"ADULT, OLDER_ADULT",NA,
NCT06052605,Healthy Aging in People With Epilepsy Program,https://clinicaltrials.gov/study/NCT06052605,NO,Epilepsy,BEHAVIORAL: Healthy Aging in People with Epilepsy Program,ALL,"ADULT, OLDER_ADULT",NA,"University of Califonia, San Diego, San Diego, California, 92093, United States"
NCT05200455,Microelectrodes in Epilepsy,https://clinicaltrials.gov/study/NCT05200455,YES,Epilepsy,DEVICE: Microelectrodes,ALL,"ADULT, OLDER_ADULT",NA,"Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, 03756, United States"
NCT04944641,"Epilepsy Prevalence and Intervention Study in Zhejiang Province, China",https://clinicaltrials.gov/study/NCT04944641,NO,Epilepsy,BEHAVIORAL: education on epilepsy|DRUG: routine and proper antiepileptic drugs,ALL,"CHILD, ADULT, OLDER_ADULT",NA,"2nd Affiliated Hospital, School of Medicine, Zhejiang University, China, Hangzhou, Zhejiang, China|Shengzhou People's Hospital, Shengzhou, China"
NCT01281956,PRX-00023 Therapy in Localization-Related Epilepsy,https://clinicaltrials.gov/study/NCT01281956,YES,"Epilepsy|Epilepsy, Temporal Lobe|Partial Epilepsy",DRUG: PRX-00023|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States"
NCT06346262,Seizure Rescue Medication (RM) as Part of a Comprehensive Epilepsy Self-management Package of Care,https://clinicaltrials.gov/study/NCT06346262,NO,Epilepsy,BEHAVIORAL: SMART RM|DRUG: Valtoco Nasal Product,ALL,"ADULT, OLDER_ADULT",PHASE4,"University Hospitals Medical Center, Cleveland, Ohio, 44106, United States"
NCT04692701,Pulvinar Stimulation in Epilepsy: a Pilot Study,https://clinicaltrials.gov/study/NCT04692701,NO,Epilepsy,DEVICE: Pulvinar deep brain stimulation,ALL,ADULT,NA,"Service de Neurologie, Nice, 13385, France"
NCT05335187,Hybrid Micro-macro Electrodes in Patients With Epilepsy,https://clinicaltrials.gov/study/NCT05335187,NO,Epilepsy,DEVICE: micro-macro electrode implantation,ALL,"ADULT, OLDER_ADULT",NA,"Hôpitaux Universitaires de Genève, Genève, CH, 1205, Switzerland"
NCT01273129,Surgery as a Treatment for Medically Intractable Epilepsy,https://clinicaltrials.gov/study/NCT01273129,NO,"Epilepsy|Epilepsy, Temporal Lobe|Partial Epilepsy",,ALL,"CHILD, ADULT, OLDER_ADULT",,"National Institutes of Health Clinical Center, Bethesda, Maryland, 20892, United States"
NCT02952456,Phenomenological Approach of Epilepsy in Patients With Epilepsy,https://clinicaltrials.gov/study/NCT02952456,NO,Epilepsy,OTHER: interview with a psychologist,ALL,"CHILD, ADULT, OLDER_ADULT",,"Uhmontpellier, Montpellier, 34295, France"
NCT04559919,Prospective Regional Epilepsy Database,https://clinicaltrials.gov/study/NCT04559919,NO,Epilepsy,OTHER: Seizure status|DIAGNOSTIC_TEST: Tests|OTHER: Epilepsy|OTHER: Demographics and psychosocial|OTHER: Health care,ALL,"ADULT, OLDER_ADULT",,"Södra Älvsborgs Sjukhus, Borås, Sweden|Sahlgrenska University Hospital, Gothenburg, 41345, Sweden|Sjukhusen i Väster, Gothenburg, Sweden"
NCT06082999,Gene-STEPS: Shortening Time of Evaluation in Paediatric Epilepsy Services,https://clinicaltrials.gov/study/NCT06082999,NO,Epilepsy,,ALL,CHILD,,"Boston Children's Hospital, Boston, Massachusetts, 02115, United States|Murdoch Childrens Research Institute, Parkville, Victoria, 3052, Australia|The Hospital for Sick Children, Toronto, Ontario, M5G 1X8, Canada|UCL Great Ormond Street Institute of Child Health, London, WC1N 1DZ, United Kingdom"
NCT00594945,Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures,https://clinicaltrials.gov/study/NCT00594945,YES,Epilepsy,DRUG: Clonazepam,ALL,"ADULT, OLDER_ADULT",PHASE2,"Clinical Trials. inc., Little Rock, Arkansas, 72205, United States|Mid-Atlantic Epilepsy & Sleep Center, Bethesda, Maryland, 20817, United States|Columbia Comprehensive Epilepsy Center, Neurological Institute, New York, New York, 10032, United States|Ohio State University, Columbus, Ohio, 43210, United States|Neurological Clinic of Texas, PA, Dallas, Texas, 75232, United States|Tampere University Hospital, Tampere, 33521, Finland"
NCT05637086,Clinical Study Evaluating Safety of Pentoxifylline in Patients With Grand-Mal Epilepsy Treated by Phenytoin Monotherapy,https://clinicaltrials.gov/study/NCT05637086,NO,Epilepsy,DRUG: Phenytoin|DRUG: Pentoxifylline 400 MG,ALL,"ADULT, OLDER_ADULT",PHASE2,"Mansoura University, Mansoura, 35516, Egypt"
NCT06202196,Risk Prevention Program and Therapeutic Patient Education Program of Patients With Uncontrolled Epilepsy,https://clinicaltrials.gov/study/NCT06202196,NO,Epilepsy,PROCEDURE: Risk prevention session|PROCEDURE: Usual Therapeutic Patient Education (TPE) management,ALL,ADULT,NA,"CHU Gui de Chauliac, Montpellier, France"
NCT05096871,Association of Brain Derived Neurotrophic Factor (BDNF) rs6265 Gene Polymorphism With Susceptibility to Epilepsy,https://clinicaltrials.gov/study/NCT05096871,NO,Epilepsy,GENETIC: Genotyping by Real Time PCR,ALL,CHILD,,
NCT05325047,Preoperative Speech Rehabilitation in Drug-Resistant Temporal Epilepsy: A Case Study,https://clinicaltrials.gov/study/NCT05325047,NO,Epilepsy,PROCEDURE: Intensive speech rehabilitation,ALL,"ADULT, OLDER_ADULT",NA,"CHU Bordeaux, Bordeaux, 33000, France"
NCT00537940,Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures,https://clinicaltrials.gov/study/NCT00537940,YES,"Epilepsy|Partial Seizure Disorder|Epilepsies, Partial|Complex Partial Seizure Disorder",DRUG: Pregabalin|DRUG: Gabapentin,ALL,"ADULT, OLDER_ADULT",PHASE4,"Hospital Clinica Biblica, San Jose, Costa Rica|Instituto de Neurociencias, San Salvador, 01503, El Salvador|Clinica de Especialidades Neurologicas, San Salvador, El Salvador|Private Office, Guatemala Ciudad, 01014, Guatemala|Private Office, Guatemala, Guatemala|Clinica Anglo Americana, Lima, 27, Peru|Torre de Consultorios Clinica Anglo Americana, Lima, L-27, Peru|Hospital Nacional Guillermo Almenara Irigoyen - Essalud, Lima, L13, Peru"
NCT00706160,Language Mapping in Patients With Epilepsy,https://clinicaltrials.gov/study/NCT00706160,NO,"Epilepsy|Epilepsy, Temporal Lobe|Partial Epilepsy",,ALL,"CHILD, ADULT",,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States"
NCT04876820,Impact of Pharmaceutical Interviews on the Medication Adherence of Epileptic Patients,https://clinicaltrials.gov/study/NCT04876820,NO,Epilepsy,OTHER: Pharmacist intervention|OTHER: Standard of care,ALL,"ADULT, OLDER_ADULT",NA,"Hopital Roger Salengro, CHU Lille, Lille, 59037, France"
NCT00522418,Study Comparing Best Medical Practice With or Without VNS Therapy in Pharmacoresistant Partial Epilepsy Patients,https://clinicaltrials.gov/study/NCT00522418,YES,Epilepsy|Partial Epilepsy,DEVICE: Vagal Nerve Simulation (VNS) Therapy|DRUG: Best Medical Practive,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,"ULB-Hôpital Erasme, Centre de référence pour le traitement de l'épilepsie réfractaire - Neurologie, Brussels, 1070, Belgium|UZ Gent, Department of Neurology, 1K12/A, Gent, 9000, Belgium|Foothills Hospital, Neurology Department, Calgary, Alberta, T1Y6J4, Canada|QEII Health Sciences Centre, Halifax, Nova Scotia, B3H 3A7, Canada|Hopital Notre Dame, Montreal, Quebec, H2L 4M1, Canada|Montreal Neurological Institute, Clinical Research, Montreal, Quebec, H3A 2B4, Canada|CHU Grenoble, Neurology Department, Grenoble, 38043, France|Hopital Roger Salengro, Service de Neurologie, Lille, 59037, France|Hôpital Neurologique, Untité d'épileptologie, Lyon, 69003, France|Hôpital Gui De Chauliac, Service Explorations Neurologiques et Epileptologie, Montpellier, 34295, France|Hôpital Sainte-Anne, Service de Neurochirurgie, Paris, 75674, France|Service d'exploration des épilepsies, Strasbourg, 67091, France|CHU Tours, Service de neurologie, Tours, 37044, France|Universitätskliniken Bonn, Klinik für Epileptologie, Bonn, 53105, Germany|Universitätsklinik Erlangen, Zentrum für Epilepsie ZEE, Erlangen, 91054, Germany|Klinik der Ernst-Moritz-Arndt-Universität, Neurologische Klinik, Greifswald, 17487, Germany|Epilepsiezentrum Kork, Kehl-Kork, 77694, Germany|Klinikum der Philips-Universität Marburg, Fachbereich, 20 - Medizin / Klinik Neurologie / Epilepsie Zentrum, Marburg, 35039, Germany|Sächsisches Epilepsiezentrum Radeberg, Epilepsiezentrum Kleinwachau, Radeberg, 01465, Germany|Azienda Ospedaliero Universitaria - Ospedali Riuniti Umberto I - Lancisi - Salesi, NeuroPsichiatria Infantile, Ancona, 60100, Italy|Universita di Bologna, Clinica Neurologica, Bologna, 40123, Italy|Azienda Ospendaliero-Universitaria, Caressi Dep Neuroscience, Firenze, 50100, Italy|Ospedale San Paolo, Centro Epilessia, Milano, 20142, Italy|Universita degli Studi di Cagliari - Policlinico Monserrato, Clinica Neurologica, Monserrato, 09042, Italy|Universita di Pisa, Clinica Neurologica, Pisa, 56126, Italy|Ospedale F. Lotti, NeuroFisioPatalogia, Pontedera, 56025, Italy|Azienda Ospedaliera ""Bianchi Melacrino Morelli"", Centro Regionale Epilessie, Reggio Calabria, 89100, Italy|Università Cattolica Del Sacro Cuore, Istituto di NeuroChirurgia, Roma, 00168, Italy|Centro Epilessia, Dipartimento di Neuroscienze, Torino, 10126, Italy|Tergooiziekenhuizen, Dienst Neurologie, Blaricum, 1261, AN, Netherlands|Medisch Spectrum Twente, Dienst Neurologie, Enschede, 7513 R, Netherlands|Stichting Epilepsie Instituut Nederland, Dienst Neurologie, Heemstede, 8025 BV, Netherlands|Kempenhaeghe, Dienst Neurologie, Oosterhout, 4901 ZG, Netherlands|Medisch Centrum Rijnmond-Zuid, locatie Clara, Dienst Neurologie, Rotterdam, 3078 HT, Netherlands|Spesialsykehuset for Epilepsi, Dep of Neurodiagnostics, Sandvika, 1306, Norway|Hospital Ruber Internacional, Servicio de neurología, Madrid, 28034, Spain|Hospital Clínico de Santiago, Santiago de Compostela, 15706, Spain|Hospital Clínico Universitario, Servicio de neurología, Valencia, 46010, Spain|Hospital General de Valencia, Neurology/Neurophisiology, Valencia, 46014, Spain|Hospital General Basico De La Defensa de Valencia, Servicio de neurología, Valencia, 46930, Spain|Institute of Neuroscience and Physiology, Clinical Neuroscience and Rehabilitation, Goteborg, 41345, Sweden|Universitetssjukhuset i Lund, Neurologiska kliniken, Lund, 221 85, Sweden|Norrlands Universitetssjukhus, Neurocentrum, Umea, 901 85, Sweden|Akademiska sjukhuset, Neurocentrum, Uppsala, 751 85, Sweden|Addenbrookes Hospital, Dept of Neurosurgery, Cambridge, CB2 2QQ, United Kingdom|Walton Centre, Dept of Neurosciences, Clinical Sciences Centre, Fazakerley, L97LJ, United Kingdom|Kings College Hospital, Dept of Neurosurgery, London, SE5 9RS, United Kingdom|National Hospital for Neurology and Neurosurgery, London, WC1N3B, United Kingdom"
NCT00851331,Genetic Basis of Idiopathic Focal Epilepsies With Cognitif Deficits,https://clinicaltrials.gov/study/NCT00851331,NO,Epilepsy,GENETIC: genome analyzes (genetic defects and pathophysiological mechanisms ),ALL,"CHILD, ADULT, OLDER_ADULT",NA,"Hôpital Femme Mère Enfant - Hospices Civils de Lyon, Service Epilepsie, Sommeil et Exploration fonctionnelle neurologique pédiatrique, Bron, 69500, France|American Memorial Hospital, CHU de Reims, Unité de Neurologie Pédiatrique - Service Pédiatrie A, Reims, 51092, France|Clinique neurologique, Hôpitaux Universitaires de Strasbourg, Strasbourg, 67091, France|Hôpital de Hautepierre, Service de pédiatrie 1, Strasbourg, 67098, France"
NCT06427967,A Novel Social Emotional Learning Curriculum for Youth With Epilepsy,https://clinicaltrials.gov/study/NCT06427967,NO,Epilepsy,BEHAVIORAL: Project Dream Team,ALL,"CHILD, ADULT",NA,"Boston Medical Center, Neurology and remote, Boston, Massachusetts, 02118, United States"
NCT05722951,Metformin Efficacy and Safety in Epileptic Patients,https://clinicaltrials.gov/study/NCT05722951,NO,Epilepsy,DRUG: Levetiracetam|DRUG: Metformin,ALL,"ADULT, OLDER_ADULT",PHASE3,"Omnia Ashraf Abd El Aziz Ahmed Kotb, Alexandria, Egypt"
NCT02358538,Open-Label PoC Trial of Ganaxolone in Children With PCDH19 Female Pediatric Epilepsy and Other Rare Genetic Epilepsies,https://clinicaltrials.gov/study/NCT02358538,YES,Epilepsy,DRUG: Ganaxolone,ALL,"CHILD, ADULT",PHASE2,"Phoenix Children's Hospital, Phoenix, Arizona, 85016, United States|Sutter Institute for Medical Research, Sacramento, California, 95816, United States|University of California San Francisco, San Francisco, California, 94143, United States|Center for Rare Neurological Diseases, Norcross, Georgia, 30093, United States|JWM Neurology, Indianapolis, Indiana, 46239, United States|Boston Children's Hospital, Boston, Massachusetts, 02115, United States|Northeast Regional Epilepsy Group, Hackensack, New Jersey, 07601, United States|Institute of Neurology and Neurosurgery at St. Barnabas, Livingston, New Jersey, 07039, United States|Nationwide Children's Hospital, Columbus, Ohio, 43205, United States|Bambino Gesu Children's Hospital, IRCCS, Rome, 00165, Italy"
NCT05491369,Effectiveness of an Epilepsy Application for Self-management in Viet Nam,https://clinicaltrials.gov/study/NCT05491369,NO,Epilepsy,OTHER: Epilepsy application,ALL,"ADULT, OLDER_ADULT",NA,"Nguyen Tri Phuong Hospital, Ho Chi Minh City, 700000, Vietnam|University Medical Center at Ho Chi Minh City, Ho Chi Minh City, 70000, Vietnam"
NCT05552924,Self Acupressure on Fatigue and Sleep Quality in Epilepsy Patients,https://clinicaltrials.gov/study/NCT05552924,NO,Epilepsy,OTHER: Self-Acupressure,ALL,"ADULT, OLDER_ADULT",NA,"Firat University, Elazıg, Turkey"
NCT06175247,Low-Glycemic (LGI) Diet in Pregnant People With Epilepsy,https://clinicaltrials.gov/study/NCT06175247,NO,Epilepsy,OTHER: Low Glycemic Index Diet,FEMALE,ADULT,NA,"Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States"
NCT06352476,The Effect of Sleep Hygiene Given to Epilepsy Patients on Seizure Frequency and Sleep Quality,https://clinicaltrials.gov/study/NCT06352476,NO,Epilepsy,BEHAVIORAL: Sleep Hygiene Training,ALL,"ADULT, OLDER_ADULT",NA,"Marmara University, Istanbul, Turkey"
NCT06105645,Contribution of Fast-ripples to the Improvement of the Neurosurgical Management of Drug-refractory Epilepsy,https://clinicaltrials.gov/study/NCT06105645,NO,Epilepsy,DEVICE: DIXI Medical Microdeep® Micro- Macro Depth electrodes|DEVICE: Standard electrodes,ALL,"ADULT, OLDER_ADULT",NA,"CHU Amiens Picardie, Amiens, France|CHU de Lille, Lille, France|Hospices Civils de Lyon, Lyon, France|CHRU de Nancy, Nancy, France|CHU de Rennes, Rennes, France|Hôpitaux universitaires de Strasbourg, Strasbourg, France|University Hospital of Toulouse, Toulouse, 31059, France"
NCT05307146,Brain Activity in Epilepsy,https://clinicaltrials.gov/study/NCT05307146,NO,Epilepsy,DEVICE: macro/micro electrode recording,ALL,"ADULT, OLDER_ADULT",NA,"UZ Leuven, Leuven, 3000, Belgium"
NCT05559060,Comorbidities of Epilepsy(Cognitive and Psychiatric Dysfunction),https://clinicaltrials.gov/study/NCT05559060,NO,Epilepsy,,ALL,"ADULT, OLDER_ADULT",,
NCT05992402,Readiness Brain Operation Optimization Training (ReBOOT) for Epilepsy Surgery,https://clinicaltrials.gov/study/NCT05992402,NO,Epilepsy,BEHAVIORAL: ReBOOT program,ALL,ADULT,NA,"Cleveland Clinic, Cleveland, Ohio, 44195, United States"
NCT05290610,Intracranial Stimulation Mapping In Epilepsy,https://clinicaltrials.gov/study/NCT05290610,NO,Epilepsy,OTHER: Functional mapping,ALL,"ADULT, OLDER_ADULT",NA,"University of Minnesota, Minneapolis, Minnesota, 55455, United States"
NCT06334029,Observational Study of the Structural-functional Connectome in Patients With Epilepsy,https://clinicaltrials.gov/study/NCT06334029,NO,Epilepsy,DIAGNOSTIC_TEST: Functional and structural Connectome,ALL,"CHILD, ADULT, OLDER_ADULT",,"IRCCS E.Medea, Conegliano, Treviso, 31015, Italy"
NCT05182437,Precision Radiation Treatment for Epilepsy (PRECISION),https://clinicaltrials.gov/study/NCT05182437,NO,Epilepsy,RADIATION: LINAC-based Stereotactic Radiotherapy,ALL,"ADULT, OLDER_ADULT",NA,"Maastricht Radiation Oncology, Maastricht, Limburg, 6202 AZ, Netherlands"
NCT02318446,Efficacy Study of Folic Acid Supplementation in Adolescent Epileptics,https://clinicaltrials.gov/study/NCT02318446,NO,Epilepsy,DRUG: Folic Acid|DRUG: Saccharine,ALL,"CHILD, ADULT",PHASE3,"Smt. Kashibai Navale Medical College and General Hospital, Pune, Maharashtra, 411041, India"
NCT04290975,Bridging the Childhood Epilepsy Treatment Gap in Africa,https://clinicaltrials.gov/study/NCT04290975,NO,Epilepsy,OTHER: Task-shifting of follow-up care for pediatric epilepsy|OTHER: Enhanced usual care for pediatric epilepsy,ALL,CHILD,NA,"Federal Neuro-Psychiatric Hospital, Kaduna, Nigeria|Aminu Kano Teaching Hospital, Kano, Nigeria|Ahmadu Bello University Teaching Hospital, Zaria, Nigeria"
NCT04967326,Role of Clinical Pharmacists in Epilepsy Management,https://clinicaltrials.gov/study/NCT04967326,NO,Epilepsy,"DRUG: Optimizing therapy with antiepileptic drugs (carbamazepine, phenytoin, valproic acid)",ALL,"ADULT, OLDER_ADULT",PHASE4,
NCT05359003,Steps for Epilepsy,https://clinicaltrials.gov/study/NCT05359003,NO,Epilepsy,BEHAVIORAL: 12-week physical activity program,ALL,"ADULT, OLDER_ADULT",NA,"Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina, 27046, United States"
NCT02726919,Clobazam Adjunctive Treatment of Adults With Refractory Focal Epilepsy,https://clinicaltrials.gov/study/NCT02726919,NO,Epilepsy,DRUG: Clobazam,ALL,"ADULT, OLDER_ADULT",PHASE4,"MidAtlantic Epilepsy and Sleep Center, Bethesda, Maryland, 20817, United States"
NCT05944692,Epilepsy Seizure Detection With Innovative Tripolar EEG (tEEG),https://clinicaltrials.gov/study/NCT05944692,NO,Epilepsy,DEVICE: Tripolar electroencephalography,ALL,"CHILD, ADULT, OLDER_ADULT",,"Barrow Neurological Institute Dignity Health dba St. Joseph's Hospital and Medical Center, Phoenix, Arizona, 85013, United States|Boston Children's Hospital, Boston, Massachusetts, 02115, United States"
NCT03926273,Serum and Urine Ghrelin in Adult Epileptic Patients,https://clinicaltrials.gov/study/NCT03926273,NO,Epilepsy,,ALL,"ADULT, OLDER_ADULT",,"Nageeb, Zagazig, El Sharkia, 002, Egypt"
NCT04749901,Symptoms of Post-traumatic Stress in Adult Drug-resistant Epilepsies,https://clinicaltrials.gov/study/NCT04749901,NO,Epilepsy,OTHER: Psycho-emotional and semiological measures,ALL,ADULT,NA,"Assistance Publique Hopitaux de Marseille, Marseille, 13354, France"
NCT05741541,How Would the Creation of a Follow-up Methodology in Consultation Improve the Care of the Epileptic Patient?,https://clinicaltrials.gov/study/NCT05741541,NO,Epilepsy,,ALL,"ADULT, OLDER_ADULT",,"Hôpital Nord Franche-Comté, Trévenans, 90400, France"
NCT06388174,Idiopathic Generalized Epilepsy Syndromes,https://clinicaltrials.gov/study/NCT06388174,NO,"Epilepsy|Epilepsy, Idiopathic Generalized",,ALL,"CHILD, ADULT",,"2nd Affiliated Hospital, School of Medicine, Zhejiang University, China, Hangzhou, Zhejiang, 310000, China"
NCT04924933,Evaluation of Memory and Forgetting in Patients With Epilepsy,https://clinicaltrials.gov/study/NCT04924933,NO,Epilepsy,DIAGNOSTIC_TEST: Computerised associative memory task using abstract words and landscape photographs,ALL,ADULT,NA,"Hospices Civils de Lyon Service de Neurologie Fonctionnelle et d'Epileptologie, Bron, 69500, France"
NCT04687904,Mindfulness Meditation for Epilepsy,https://clinicaltrials.gov/study/NCT04687904,NO,Epilepsy,BEHAVIORAL: Mindfulness meditation training|BEHAVIORAL: Therapeutic education,ALL,"CHILD, ADULT, OLDER_ADULT",NA,"Centre Hospitalier Universitaire, Rennes, 35033, France"
NCT04106284,Comorbidities of Epilepsy,https://clinicaltrials.gov/study/NCT04106284,NO,Epilepsy,,ALL,"ADULT, OLDER_ADULT",,
NCT03738072,Intracerebral Electrical Stimulation and the Optimisation of Presurgical Planning in Drug-refractory Partial Epilepsy,https://clinicaltrials.gov/study/NCT03738072,NO,Epilepsy,DIAGNOSTIC_TEST: StiMiC stimulation condition,ALL,"CHILD, ADULT, OLDER_ADULT",NA,"CHU de Toulouse, Toulouse, 3100, France"
NCT00165828,Efficacy and Safety of an add-on Treatment With Zonisamide in Adults With Focal Epileptic Seizures With or Without Secondary Generalization,https://clinicaltrials.gov/study/NCT00165828,NO,Epilepsy,DRUG: Zonegran,ALL,"ADULT, OLDER_ADULT",PHASE4,"Epilepsieklinik Tabor, Bernau, Brandenburg, 16321, Germany|Universtitatsklinikum Bonn, Bonn, Nordrhein-Westphalen, 53105, Germany|Universtitatsklinikum Munster, Klinik und Poliklinik fur Neurologie, Munster, Nordrhein-Westphalen, 48129, Germany|Epilepsiezentrum Bethel/KSE, Beilefeld, 33617, Germany|Institut fur Diagnostik der Epilepsien Gmbh, Berlin, 10362, Germany|Charite Campus Virchow-Klinikum, Neurologische Klinik und Poliklinik, Berlin, 13353, Germany|St. Josephs Hospital, Neurologische Klinik, Bochum, 44791, Germany|Dr. Gunther Schumann, Bochum, 44805, Germany|Knappschaftskrankenhaus Bochum-Langendreer, Neurologische Klinik, Bochum, 44892, Germany|Dr. Hans Martin Kolbinger, Bonn, 53127, Germany|Neuro-Consil Gmbh, Dusseldorf, 40212, Germany|Neurologische Klinik der Universitat Erlangen, Erlangen, 91054, Germany|Universitatsklinik Essen, Klinik und Poliklinik fur Neurologie, Essen, 45147, Germany|Universitatsklinikum Freiburg, Neurozentrum, Freiburg, 79106, Germany|Universitatsklinikum Gottingen, Abt. fur klinische Neurophysiologie, Gottingen, 37075, Germany|Gemeinschaftpraxis fur Neurologie und Psychiatrie, Hamburg, 22083, Germany|Dr. Heinrich C. Braeuer, Hamburg, 22299, Germany|Ev. Krankenhaus Alsterdorf, Epilepsiezentrum Alsterdorf, Hamburg, 22337, Germany|Epilepsiezentrum Kork, Kehl, 77694, Germany|Epilepsiezentrum Kleinwachau, Epilepsieambulanz, Liegau-Augustusbad, 01465, Germany|Universitatsklinikum Mannheim, Neurologische Klinik, Ambulanz fur Anfallserkrankte, Mannheim, 68167, Germany|Universitatsklinikum, Interdisziplinares Epilepsiezentrum, Marburg, 35043, Germany|Klinikum Grosshadern, Neurologische Klinik und Poliklinik, Epilepsie-Ambulanz, Munchen, 81377, Germany|Klinikum Offenbach, Neurologie, Offenbach, 63069, Germany|Klinik Ernst von Bergmann, Potsdam, 14467, Germany|Universitat Regensburg, Klinik un Poliklinik fur Neurologie, Regensburg, 93053, Germany|Klinik ""Die Weissenau"", Anfallsambulanz, Revensburg, 88214, Germany|Universitat Rostock, Klinik fur Neurologie und Poliklinik, Rostock, 18147, Germany|Universitatsklinik Ulm Poliklinik fur Neurologie, Epilepsieambulanz, Ulm, 89075, Germany|Dr. Horst-Schmidt Klinik, Neurologie, Wiesbaden, 65199, Germany"
NCT05127499,The Effect of Progressive Relaxation Exercises Applied to Patients With Epilepsy,https://clinicaltrials.gov/study/NCT05127499,NO,Epilepsy,OTHER: progressive relaxation exercises,ALL,ADULT,NA,"Fırat Üniversitesi, Elazığ, Turkey"
NCT05864612,Tools for Anxiety and Depression Screening in Epilepsy,https://clinicaltrials.gov/study/NCT05864612,NO,Epilepsy,BEHAVIORAL: Screening Questionnaires,ALL,"ADULT, OLDER_ADULT",NA,"Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina, 27157, United States"
NCT06180538,Exploring Patient Impact & Value in Epilepsy Wearables for Seizure Monitoring,https://clinicaltrials.gov/study/NCT06180538,NO,Epilepsy,,ALL,"ADULT, OLDER_ADULT",,
NCT06321822,Genetic Diagnosis and Personalized Medicine for Patients With Epilepsy,https://clinicaltrials.gov/study/NCT06321822,NO,Epilepsy,DIAGNOSTIC_TEST: Whole exome sequencing (WES),ALL,"CHILD, ADULT, OLDER_ADULT",NA,"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, 20122, Italy"
NCT04725162,Epileptogenic Focus Localization for Children With Epilepsy Using 18F-FDG PET Molecular Imaging,https://clinicaltrials.gov/study/NCT04725162,NO,Epilepsy,RADIATION: 18F-FDG,ALL,"CHILD, ADULT",,"Department of Nuclear Medicine and PET/CT Center, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, China"
NCT04569071,Clinical Trial of MgLiTT for Medical Refractory Epilepsy,https://clinicaltrials.gov/study/NCT04569071,NO,Epilepsy,DEVICE: Sinovation Laser Ablation System,ALL,"CHILD, ADULT, OLDER_ADULT",NA,"Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing, 100070, China"
